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The body of this thesis is comprised of four scientific journal articles and a patent. It is 
preceded by an overview that contextualizes all of this submitted/published work. 
The first major part of this thesis is comprised of Publication 1. This is a review 
concerned with the chemical syntheses of the cochliomycins, including congener A, and 





Specifically, Publication 1 reviews the recently published literature on the 
cochliomycins and related, co-occurring RALs and is accompanied by a brief 
commentary on the source organisms and certain of their biological properties. It serves 
to contextualize some of the author’s other published research incorporated in the thesis. 
The second major part of this thesis is comprised of Publication 2. This details work 
concerned with establishing the true structure of the marine-derived RAL neocosmosin 
A. Specifically, the structure, A, originally assigned to neocosmosin A was synthesized 
with the key steps involving olefin-cross metathesis, ring-closing metathesis, palladium-
catalyzed Meinwald rearrangement and Mitsunobu esterification reactions. A late-stage 
and simple modification to the reaction sequence also provided the enantiomer B that, 
in fact, represents the true structure of the natural product. 
 
 

















The third major part of this thesis is comprised of Publication 3. This details the 
development of modular total syntheses of the marine-derived alkaloids discoipyrroles 
A and B. 
 
 
                                            discoipyrrole A                          discoipyrrole B 
 
Specifically, the intermediates C and D (see below) were prepared from (parent) pyrrole 
using Ullmann-Goldberg and Suzuki-Miyaura cross-coupling, Vilsmeier-Haack 
formylation, electrophilic bromination, and Wittig olefination reactions as key steps. A 
late stage MoOPH-mediated oxidative cyclization reaction was then employed to 
assemble the novel heterobicyclic core of the target discoipyrroles. 
 
 
                                                            C                                                    D 
 
The fourth major part of this thesis is comprised of Publication 4. This details the first 
total synthesis of the most structurally complex member of the small family of marine-
derived discoipyrroles, namely congener D. This synthesis, which used methodology 
developed during the course of the aforementioned syntheses of the discoipyrroles A 
and B, involved, as key steps, the MoOPH-mediated oxidative cyclization of precursor 




















                                      discoipyrrole D                                                                E 
 
The fifth and final part of this thesis is comprised of Publication 5. This patent details 
inventions related to methods for preparing a variety of discoipyrrole-like compounds 
and novel analogues, as well as pharmaceutical compositions comprising these 
compounds and their possible use in therapeutic settings. For example, compound F, 
which incorporates a discoipyrrole-like core structure, was synthesized in four steps 
from indole and involving the aforementioned MoOPH-mediated oxidative cyclization 





The Appendices to the thesis are comprised of a series of reports arising from single-
crystal X-ray analyses of certain key compounds synthesized by the author. Drs Jas 
Ward, Paul Carr or Anthony Willis, members of the Research School of Chemistry’s 



























Publication 1: Chemical Syntheses of the Cochliomycins and Certain Related 
Resorcylic Acid Lactones 
The resorcylic acid lactones (RALs) are a large and ever-growing group of mycotoxins 
that embody a β-resorcylic acid residue annulated to a 14-membered macrolactone.1,2 
RALs are notable for the frequency with which they are isolated from fungal sources, 
their distinctive structural features and their breadth of biological activities.1 Radiciol (1) 
was the first RAL to be isolated (from Monosporium nordinii) and characterized in the 
1950s.3 In the intervening period numerous other RALs have been identified and these 
vary in the nature of the substitution pattern on the aromatic ring as well as the location 
and degree of unsaturation and/or oxygenation within the macrolactone ring. The 
structures of the RALs hypothemycin (2), zearalenone (3), pochonin C (4), L-783,277 




Figure 1: Examples of Structural Variations Possible Within the RALs 
 
A significant number of members of this large class of natural product display a 
fascinating array of biological properties, including antifungal, antimalarial, mycotoxic, 
antibacterial, and/or anticancer activities.1 As a recently discovered subset of RALs, 
cochliomycins A-F (7-12) (Figure 2), which have been isolated from the culture broths 
























































gorgonian Dichotella gemmacea or the sea anemone Palythoa haddoni, respectively, 
are potent yet environmentally benign anti-fouling agents.2a, 2c  
 
Figure 2: The Structures of Cochliomycins A-F (7-12, respectively). 
 
As with other RALs, the cochliomycins have been the subject of various synthetic 
studies, both for the purposes of confirming their structures and as a means of providing 
more material (as well as analogues). 
This publication reviews the synthetic work carried out on cochliomycins that has been 
reported in the literature to date.4 One of the first syntheses was reported by Du and co-
workers (Scheme 1) who employed L-arabinose (13) as the chiron for assembling the 
three contiguous stereogenic centres contained within the target macrolide. 
Lactone/alcohol 14 was synthesized from this chiron through a series of chemical 
transformations and a base-promoted lactonization reaction was applied to this 
compound to establish the macrocyclic ring associated with cochliomycin A (7). 
 
 



















































































This review also outlines some recent investigations conducted by the Banwell research 
group into the total syntheses of cochliomycins A-C and certain related RALs.5 
Publication 2: Total Syntheses of the Resorcylic Acid Lactone Neocosmosin A and 
Its Enantiomer 
Neocosmosins A-C, which were recently isolated by Culter and co-workers from a 
fungus Neocosmospora sp. (UM-0351509) and assigned structures 15-17, respectively 
(Figure 3), are also examples of resorcylic acid lactones (RALs). Certain of these 
compounds display good in vitro binding affinity for the human opioid and cannabinoid 




Figure 3: The Structures of the Neocosmosins A-C (15-17, respectively) 
 
Publication 2 details the author’s investigations into the total synthesis of compound 1 
and its enantiomer (ent-1) and thereby establishing, in fact, that it is the latter structure 
that corresponds to the natural product neocosmosin A.  
The author’s synthesis started with the olefin-cross metathesis (OCM) of the previously 
reported and readily accessible resorcylic acid derivative 185a with the known7 
unsaturated acetal 19 that is readily generated from cyclohexene. The almost 
exclusively E-configured alkene 20 formed by such means was subjected to 
dimethyldioxirane (DMDO) mediated epoxidation8 and palladium-catalysed Meinwald 
rearrangement9 of the product epoxide gave ketone 21. Hydrolysis of the acetal residue 
within compound 21 and Wittig reaction of the resulting keto-aldehyde then gave 
terminal olefin 22. A Mitsunobu esterification reaction with (R)-(+)-4-penten-2-ol (23) 
then followed to afford ester ent-24 that was itself converted into macrolide ent-1 on 
exposure to the Grubb’s II catalyst (Scheme 2).  
The structure assigned to the synthetic material ent-1 was in full accord with the derived 
spectral data but final confirmation of this (including the illustrated absolute 

















neocosmosin A neocosmosin B neocosmosin C
	 8	
specific rotation of the synthetically derived material ent-1 compared very favorably, in 
terms of both magnitude and sign, with that reported for the natural product. 
 
Scheme 2 Key Steps Involved in the Synthesis of Neocosmosin A 
 
Publication 3: Modular Total Syntheses of the Alkaloids Discoipyrroles A and B, 
Potent Inhibitors of the DDR2 Signaling Pathway 
The discoipyrroles A-D are four alkaloids isolated by MacMillan and co-workers10 from 
the marine-derived Bacillus hunanensis strain SNA-048. Each was isolated as the 
racemate (A-C) or a mixture of diastereoisomers (in the case of congener D) and 
assigned structures 25-28, respectively (Figure 4). Discoipyrroles A, B and D are the 
first examples of natural products that embody a 3H-benzo[d]pyrrole[1,3]oxazine-3,5-
dione core. All four compounds proved to be particularly strong inhibitors of the 






















































20 °C, 16 h
92%
	 9	
fascinating origins, structures, and biological activities of the discoipyrroles prompted 
the author’s investigation into the syntheses of congeners A and B (in the first instance). 
 
Figure 4: The Structures of the Discoipyrroles A-D (25-28, respectively). 
 
Starting from pyrrole 29, and through the application of Ullmann-Goldberg cross-
coupling,11 Vilsmeier-Haack formylation,12 and two-fold electrophilic bromination,13 
dibromide 30 was formed. Two-fold Suzuki-Miyaura cross-coupling of compound 30 
with the boronic acids 31 and/or 32 then gave the 1,2,3-triarylated pyrrole-2-
carboxaldehydes 33 and 34, respectively.14 The last two compounds were subjected to 
Wittig olefination followed by hydrogenation. Saponification of the carboxylic acid 
ester residues and O-demethylation then gave compounds 35 and 36, respectively. 
Finally, oxoperoxymolybdenum(pyridine)(hexamethylphosphoric triamide)15 (MoOPH) 
-mediated oxidative cyclization of these pyrroles gave the alkaloids discoipyrroles A 
and B, respectively, the derived spectral data for which were in excellent agreement 
with those reported for the natural products. The structure of discoipyrrole B was 

















25 (R = OH, discoipyrrole A)




Scheme 3 Key Steps Involved in the Syntheses of the Discoipyrroles A and B 
 
Publication 4: A Total Synthesis of the Marine Alkaloid Discoipyrrole D 
The marine-derived alkaloid discoipyrrole D, which was isolated as a mixture of 
diastereoisomers, is the most complex member of this newly discovered family of 
marine alkaloids.10 The sensitivity of the associated 3H-benzo[d]pyrrole[1,3]oxazine-
3,5-dione core thwarted the completion of a total synthesis of this natural product by 
May and co-workers.16 To confirm the basic structure assigned to discoipyrrole D by 
MacMillan and co-workers and to test the functional group tolerance of our MoOPH-
mediated oxidative cyclization reaction, the author developed a total synthesis of this 
alkaloid. So, this publication details the author’s investigations into the synthesis of 
discoipyrrole D (Scheme 4). This started with the regioselective Ullmann-Goldberg 
arylation11 of pyrrole 29, followed by Vilsmeier-Haack formylation12 and 
regiocontrolled di-iodination,17 and thereby producing compound 37. Two-fold Suzuki-
Miyaura cross coupling of di-iodide 37 with commercially available p-
hydroxyphenylboronic acid 38 then gave the tri-arylated pyrrole 39 that was itself 
transformed into cinnamaldehyde 40 over a further five steps by employing, inter alia, a 


































31 (R’ = OMe)
32 (R’ = H)
33 (R’ = OMe)
34 (R’ = H)
35 (R = OH)
36 (R = H)25 (R = OH, discoipyrrole A)26 (R = H, discoipyrrole B)
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Product 40 thereby obtained was immediately engaged in a MoOPH-mediated oxidative 
cyclization reaction so as to generate the 3H-benzo[d]pyrrole[1,3]oxazine-3,5-dione 
core in compound 41. The conjugate addition reaction of compound 41 with the readily 
prepared N-Boc-protected indole C3-trifluorborate salt 42 in the presence of the freshly 
prepared chiral catalyst (R)-3,3’-(C7F7)2-BINOL16 afforded product 43 as a 1:1 mixture 
of diastereoisomers. The total synthesis of discoipyrrrole D (28) was completed over a 
further five straightforward steps from this intermediate. All the spectral data acquired 
on compound 28, which indicated that it had been generated as a 1:1 mixture of 
diastereoisomers, proved a good match for those reported by MacMillan and co-
workers10 on discoipyrrole D. 
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Publication 5 (A Patent): Modular Synthesis of Discoipyrrole Type Alkaloids and 
Analogues 
As noted above, the recently isolated marine alkaloids known as discoipyrroles A-D 
(25-28) proved to be particularly strong inhibitors of the discoidin domain receptor 2 or 
DDR2-dependent migration of BR5 fibroblasts. They also show selective cytotoxicity 
towards DDR2 mutant lung cancer cell lines (IC50 120- 400 nM).10 As such, these 
natural products and their analogues could provide important new tools for interrogating 
the DDR2-signaling pathway, one that has been implicated in various cancers,19 
fibroblast migration and proliferation20 as well as certain obstructive diseases of blood 
vessels.21 
This publication (patent) details the authors’ inventions as they relate to methods for 
preparing the discoipyrroles and various analogues as well as pharmaceutical 
compositions comprising these compounds and their potential application in certain 
therapeutic settings. The modular syntheses described provide a facile and versatile 
means for obtaining the discoipyrroles A, B and D as well as a variety of analogues. For 
example, compound 50, which incorporates the 3H-benzo[d]pyrrole[1,3]oxazine-3,5-
dione core of the natural products, was synthesized in four steps from indole by 





Scheme 5 The Synthesis of Discoipyrrole Analogue 50 
 
Certain novel discoipyrrole analogues, including those shown in Figure 5, were 
obtained and proved to be as active as the natural products in certain biological assays 
but are more readily accessible and stable. 
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Abstract: The cochliomycins (7-12) are a group of six resorcylic acid lactones that 
have recently been isolated from culture broths of marine fungi found in the South 
China Sea. These natural products have attracted attention as synthetic targets because 
of (in certain instances) their novel structural features and their capacities to supress 
biofouling. This short review summarizes the synthesis of these and certain related 
compounds that have been reported to date, including those developed in the authors’ 
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The value of small molecule natural products (SMNPs) as therapeutic agents, as 
precursors to such agents or as the inspirations for them is well known.1 Indeed, there 
are now indications that SMNPs, perhaps especially ones derived from marine 
environments,2 are enjoying something of a renaissance not least because of their 
enormous structural diversity and their occupation of unique parts of chemical space.3 
Among the plethora of different natural product classes, the resorcylic acid lactones 
(RALs) are notable for the frequency with which they are isolated from fungal sources, 
their distinctive structural features and their breadth of biological activities.4 In the 
	 20	
following section an overview of the structural variations within the RAL class is 
provided along with a brief commentary on the source organisms and certain of their 
biological properties. As a recently discovered and interesting subset of RALs that has 
not been the subject of any previous reviews, the cochliomycins are then described and 
a summary of the synthetic work carried out on them follows.    
 
Resorcylic Acids Lactones (RALs) as a Natural Product Class 
 
The RALs are mycotoxins and the products of a distinctive polyketide biosynthesis that 
exploits an acetyl CoA starter unit together with malonyl-CoA extenders and involves 
two fungal polyketide synthases (PKS) that work co-operatively.4e Specifically, a non-
reducing PKS is coupled with a highly reducing one that enables the assembly of the 
relevant resorcylic acid core annulated to a 14-membered macrolactone (and wherein 
most of the structural variation resides). Unsurprisingly perhaps, the final step in the 
biosynthesis is the macrolactonisation event that releases the substrate from the enzyme 
complex. Post-PKS-mediated processes such as epoxidation, halogenation and 
alkylation may then follow so as to provide the fully “decorated” (isolated) 
metabolite.4e  
 
Radiciol (1) was the first RAL to be isolated (from Monosporium nordinii) and 
characterised in the 1950s4 and it has since been obtained from various other fungal 
strains. In the intervening period numerous other RALs have been identified and these 
vary in the nature of the substitution pattern on the aromatic ring as well as the location 
and degree of unsaturation and/or oxygenation within the macrolactone ring. The 
structures of the RALs hypothemycin (2), zearalenone (3), pochonin C (4), L-783,277 
(5) and aigialomycin D (6) shown in Figure 1 serve to highlight such degrees of 


























































Figure 1: Examples of the Structural Variations Possible Within the RAL Class 
 
 
Initial biological evaluation of radiciol (1) showed it to possess anti-bacterial properties 
and to act as a mild sedative. However, the later revelation that it acts as a powerful 
inhibitor of heat shock protein 90 (HSP90) - and thus representing an important lead in 
the development of oncolytic agents - caused much greater attention to be given to the 
RALs. In contrast to radiciol (1), the cis-enone-containing hypothemycin (2) has been 
shown to strongly inhibit the kinase MEK1, while zearalenone (3) acts as an estrogen 
agonist and its hormone-like properties have been shown to promote growth in cattle 
and sheep. A closely related RAL is now commercially available and employed to 
alleviate post-menopausal stress in women and as an anabolic cattle-growth stimulant. 
Pochonin C (4), on the other hand, inhibits herpes simplex virus (HSV) replication in a 
potentially therapeutically useful way while the cis-enone L-783,277 (5), like congener 
2, inhibits MEK1. Aigialomycin D (6), despite the absence of a cis-enone moiety, also 
acts as a kinase inhibitor as well as an anti-malarial agent (the latter property seemingly 
being unrelated to the former).  
 
The Discovery of Cochliomycins A-F 
 
In papers published in 20115 and 2014,6 Wang and co-workers from the Ocean 
University of China in Qingdao reported the isolation of cochliomycins A-F (7-12) 
(Figure 2) from the culture broths of Cochliobolus lunatus (M351) or C. lunatus (TA26-
46), fungi associated with the gorgonian Dichotella gemmacea or the sea anemone 
Palythoa haddoni, respectively. Both host organisms were collected in the South China 
Sea. The structures of these RALs were established through the application of the usual 
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battery of spectroscopic methods and the absolute stereochemistries of the last three 
determined using the CD exciton chirality method in conjunction with TDDFT ECD 
calculations.6  
 
The most striking features of this subset of RALs are the presence of acetonide units 
within the structures of congeners A and B (7 and 8, respectively). Since acetone was 
not used in the isolation, purification or spectroscopic characterisation of these 
compounds they must be considered as natural products rather than artefacts. Wang and 
co-workers also noted5 that on standing in CDCl3 at ambient temperatures cochliomycin 
B (8) slowly isomerised to congener 7 and so suggesting the latter is the 
thermodynamically more stable compound. Cochliomycin C (9) is the only member of 
the series lacking a second double bond within the macrocylic ring. Cochliomycins D 
(10) and E (11) are isomeric while congener F (12) is not simply a chlorinated 
derivative of one or other of the first two because of the differing configuration at one 
or other of the hydroxyl-bearing methine carbons. Nor, for the same reasons, can 
colchliomycin F (12) simply be the product of the two-fold oxidation of congener 9.  


































































Related, Co-occurring Natural Products 
 
In the course of structurally characterizing the cochliomycins, it was noted5 that 
congener C (9) is the chlorinated derivative of co-isolated paecilomycin F (13) (Figure 
3), a previously reported RAL that displays anti-malarial properties. Other RALs also 
isolated alongside compounds 7-9 were zeaenol (14), LL-Z1640-1 (15) and LL-Z1640-2 
(16). During the course of isolating cochliomycins D, E and F (10, 11 and 12, 
respectively), cochliomycin A (7), zeaenol (14), LL-Z1640-1 (15), LL-Z1640-2 (16), its 
E-isomer 17 [(7¢E)-6¢-oxozeaenol], deoxyaigialomycin C (18) and aigialomycin B (19) 
were also observed in the mixture of isolates. Clearly certain of these co-isolates are 
isomeric with the cochliomycins or otherwise closely related. For example, zeaenol (14) 







































































Biological Properties of the Cochliomycins 
 
The most notable biological properties of at least certain of the colchiomycins are their 
anti-fouling properties. So, for example, on evaluating the effects of cochliomycins A-C 
(7-9) on the larval settlement of the barnacle Balanus amphitrite, the first of these 
completely inhibited this process at concentrations of 20.0 µg/mL and still displayed 
significant effects at 5.0 µg/mL. Zeaenol (14) and compound 7 as well as two acetate 
derivatives of the latter displayed potent anti-fouling activities at non-toxic 
concentrations with EC50 values of 5.0, 1.2, 15.4 and 12.5 µg/mL, respectively. These 
values are well below the threshold requirement (EC50 25 µg/mL) set by the US Navy 
program as an efficacy level for the development of natural anti-fouling agents. Given 
the structural relationship between compounds 7 and 14, the presence of the acetonide 
moiety in the former compound clearly has a beneficial effect on anti-fouling properties. 
Furthermore, since these same compounds display high therapeutic ratios they might 
well be useful as environmentally benign anti-fouling agents. Cochliomycin A’s anti-
fouling effects are now thought to arise through stimulation of the NO/cGMP pathway 
in the cyprid lavael phase of the barnacle’s lifecycle.7 The subsequent evaluation of 
cochliomycins D, E and F revealed that the first and third of these also displayed potent 
anti-fouling effects at non-toxic concentrations (EC50 values of 17.3 and 6.67 µg/mL, 
respectively).6 Significantly, the most active compound among the isolates from the 
culture broth of C. lunatus (TA26-46) was the cis-enone-containing LL-Z1640-2 (16). 
The EC50 value of this compound  (1.82 µg/mL) is close to that of the commercially 
employed anti-fouling agent SeaNine 211™ (1.23 µg/mL)8 but has a significantly more 
favourable therapeutic ratio [LC50/EC50 >50 (for 16) vs 20.3]. The differing anti-fouling 
behaviours of cochliomycins D, E and F suggest that variations in stereochemistry can 
have a notable impact on activity. 
 
Interestingly, cochliomycin A (7) displayed moderate anti-bacterial activity against 
Staphylococcus aureus5 while, unlike cochliomycins D, E and F, LL-Z1640-2 (16) 







Synthetic Studies on the Cochliomycins 
 
As with other RALs, the cochliomycins have been the subject of various synthetic 
studies, both for the purposes of confirming their structures and as a means of providing 
more material (as well as analogues). Almost invariably, a major consideration in such 
work is the manner in which the 14-membered lactone ring is closed. A range of 
methods has been successfully employed for this purpose and these are presented within 
the individual descriptions given below of the various syntheses reported to date.     
 
(a) The Du Group Syntheses 
The Du group’s synthesis of cochliomycin A (7) was reported9 in 2014 and employed 
L-arabinose as the chiron for assembling the three contiguous stereogenic centres within 
the macrolide along with a base-promoted lactonisation reaction to close the ring itself. 
The detailed reaction sequence is shown in Scheme 1 and started with the conversion of 
L-arabinose (20) into the corresponding bis-acetonide (21) under standard conditions 
and the latter compound subjected to a Wittig olefination (to give 22) and then selective 
acetonide hydrolysis using aqueous acetic acid. Diol 23 so-formed (77% from 21) was 
selectively tosylated and ester 24 then treated with base so as to form epoxide 25 (78% 
from 23). Olefin cross-metathesis of compound 25 with the commercially available and 
S-configured alcohol 26 gave the E-alkene 27 (85%) and the associated epoxide ring 
then opened using the anion derived from trimethylsilylacetylene and thus producing 




































































































Scheme 1: The Du Group Synthesis of Cochliomycin A (7) 
 
Over three steps, including a Pd-catalysed hydrostannylation reaction, the acetylenic 
unit associated with compound 28 was converted into the alkenylstannane 29 (71%) that 
was itself engaged in a Stille cross-coupling with the well known aryl triflate 30 and 
thus producing compound 31 (81%), the immediate precursor to target 7. Indeed, on 




The Du Group’s synthesis of cochliomycin B (8) (Scheme 2)10 also started with L-
arabinose but a ring-closing metathesis reaction was now used to construct the 

























































































Scheme 2: The Du Group Synthesis of Cochliomycin B (8) 
 
Thus, compound 20 was converted, under conventional conditions, into the 
corresponding 3,4-mono-acetonide and this itself subjected to a Wittig olefination 
reaction and so affording compound 32 (72%). Over three steps this diol was 
manipulated so as to generate aldehyde 33 (46%) and a Wittig-based homologation of 
this last compound afforded, via enol ether 34 (77%), congener 35 (75%). Takai-type 
olefination of this last compound then gave the E-configured iodoalkene 36 (53%) that 
was engaged in a Suzuki-Miyaura cross-coupling with the readily obtained arylboronate 
	 28	
37 and so affording the trans-styrene 38 (68%). Reaction of this last compound with the 
anion derived from homochiral alcohol 26 then gave ester 39 (75%) that upon reaction 
with Grubbs’ second generation catalyst afforded, via ring-closing metathesis (RCM), 
the required macrocycle (67%) and treatment of this with tetra-n-butylammonium 
fluoride (TBAF) then gave cochliomycin B (8) in 85% yield. Interestingly, in the 
penultimate step there was no competing RCM involving the styrenyl double bond and 
the proximate terminal olefin (a process that would lead to side-chain fragmentation and 
formation of a cyclohexene).  
 
(b) The Nanda Group Syntheses 
Jana and Nanda reported a synthesis of cochliomycin A in 201211 and this started with 
the conversion, by well established methods, of L-(+)-tartaric acid (40) into 2,3-di-O-
isopropylidene-L-threitol (41) and mono-protection of the latter to give ether 42 (85%). 
Oxidation of compound 42 under Swern conditions gave the corresponding aldehyde 43 
(90%) that was subjected to a highly diastereoselective Keck asymmetric allylation 
reaction and so affording, after protection of the resulting homoallylic alcohol, cleavage 
of the TBS ether and oxidation of the resulting alcohol, aldehyde 44 (59%). A Julia-
Kocienski olefination reaction was then carried out on compound 44 using the readily 
prepared sulfone 45, KHMDS and 18-crown-6 and so affording, in a highly selective 
manner and after silyl ether cleavage, the target E-alkene 46 in 75% yield. Mitsunobu 
coupling of this last compound with acid 47 then gave, after cleavage of the PMB ether 
residue, ester 48 (73%). Upon exposure to Grubbs’ second-generation catalyst 















































































Scheme 3: The Nanda Group Synthesis of Cochliomycin A (7) 
 
The Nanda Group synthesis of cochliomycin C12 (Scheme 4) also started with L-tartaric 
acid (40) and exploited a Mitsunobu-mediated lactonisation reaction  to form the 
macrolide ring. Specifically, then, di-acid 40 was, once again, converted into the diol-
acetonide 41 and the latter mono-protected as the corresponding p-methoxybenzyl 
(PMB) ether 49 (85%). Upon Swern oxidation this last compound gave the aldehyde 50 
(90%), Wittig olefination of which afforded the terminal olefin 51 (70-75%) that was 
subjected to an olefin cross-metathesis (OCM) reaction with the unsaturated and 


















































































































Scheme 4: The Nanda Group Synthesis of Cochliomycin C (9) 
 
The primary product of this process was then hydrogenated under conventional 
conditions so as to give compound 53 (79%). Oxidative cleavage of the PMB-ether 
residue associated with bis-ether 53 then gave the corresponding alcohol that was 
	 31	
oxidised to aldehyde 54 (80%) using the Dess-Martin periodinane. Reaction of 
compound 54 with the propargyl anion proceeded stereoselectively and Lindlar 
hydrogenation of the product alkyne gave the corresponding homoallylic alcohol that 
was protected as the MOM-ether 55 (78%). Heck coupling of the last compound with 
the iodinated benzaldehye 56 afforded styrene 57 (84-90%) and oxidation of the 
associated aldehyde residue gave the corresponding benzoic acid. Cleavage of the 
TBDPS-ether within product 57 then afforded the substrate 58 (61-79%) used in the 
macrolactonisation reaction. So, compound 58 was subjected to an intramolecular 
Mitsunobu reaction that provided macrolide 59 (P = MOM) (78%), the MOM-group of 
which was cleaved and the product RAL, viz. paecilomycin F (13), was then chlorinated 
using sulfuryl chloride and thus affording cochliomycin C (9) in 71% yield. 
 
Nanda and his colleagues have also reported13,14 related syntheses of the C5¢- and C6¢-
epimers of cochliomycin C. 
 
(c) The Srihari Group Approach 
The Srihari Group synthesis of cochliomycin C (9)15 (Scheme 5) is a formal one [in that 
it delivers paecilomycin F (13)], relies on D-lyxose (60) as starting material and uses a 
RCM reaction to construct the macrolide ring. The synthesis started with the conversion 
of compound 60 into the previously reported mono-acetonide 61 (95%) and this was 
subjected to an Ohira-Bestmann alkyne forming reaction that delivered, with 
accompanying epimerisation, compound 62 (49%) as a mixture of diastereoisomers. 
Conversion of this last pair of compounds into the corresponding bis-acetonides and 
chromatographic separation of the major product 63 (45%) was followed by the 
regioselective reaction of the derived anion with the commercially available and 
homochiral epoxide 64 and so affording the 2°-alcohol 65 (82%). Exhaustive reduction 
of the alkyne moiety associated with this last compound and reaction of the oxyanion 
derived from product 66 (86%) with the readily prepared arene 67 then gave, after acid 
treatment, the vinylated salicylate 68 (65%). This was subjected to oxidative cleavage 
and the ensuing aldehyde allylated in a diastereoselective manner to give diene 69 
(63%). Compound 69 was then engaged in a RCM reaction using the Hoveyda-Grubbs 
second generation catalyst and by such means, and after cleavage of the associated 
acetonide residue, paecilomycin F (13) was obtained in 68% yield. Since Nanda12 has 
previously converted compound 13 into cochliomycin C (9) through electrophilic 
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aromatic chlorination using sulfuryl chloride a formal total synthesis of the latter natural 


















































































Scheme 5: The Srihari Group Synthesis of Paecilomycin F (13) 
 
By related means C6¢-epi-cochliomycin C was obtained.15 
 
(d) Background to the Banwell Group Studies on the Synthesis of RALs 
Our group’s original efforts in the area arose through an interest in exploiting 
enzymatically-derived and homochiral cis-1,2-dihydrocatechols16 such as 70 (Figure 4) 
in the assembly of various RALs. The pivotal building block employed for this purpose 
	 33	
was Weinreb amide 7117 obtained through, inter alia, reduction of the non-halogenated 
double bond associated with the acetonide derivative of diol 70 and ozonolytic cleavage 
of the remaining (halogenated) one. Compound 71 served as a precursor to L-783,290 
(72) and its cis-isomer 5, the latter being, as noted above, a potent inhibitor of MEK1. 
While the macrolide ring and the E-configured C=C bond associated with target 72 was 
constructed using a RCM reaction, a more novel means of assembling the analogous (Z-




























Figure 4: The starting material 70 and intermediate 71 used by the Banwell Group in 
establishing total syntheses of RAL L-783,290 (72) and its cis-isomer 5. 
 
Our synthesis of the cis-enone-containing L-783,277 (5) is shown in Scheme 6 and, like 
the pathway leading to congener 72, involved, on the early stages, the Heck coupling of 
aryl iodide 56 with the unsaturated Weinreb amide 71. The immediate product of this 
process was oxidised to the corresponding acid (under Pinnick conditions) and this then 
hydrogenated to give compound 73 (41%) that was, in turn, treated with the oxyanion 
derived from the homochiral propargylic alcohol 74 (itself available through enzymatic 
resolution of the corresponding racemate). The ester 75 (70%) so formed was treated 
with potassium hexamethyldisilazide so as to generate the corresponding acetylide 
anion that itself engaged in an intramolecular acylation reaction and so producing the 
cyclic alkyne 76 (45%) and for which a single-crystal X-ray analysis was undertaken. 
This analysis revealed an essentially linear geometry about the internal triple bond and 
thus highlighting the capacity of the 14-membered macrolide ring of RALs to 
accommodate a range of structural motifs. The completion of the synthesis of target 5 
involved Lindlar-type hydrogenation of cyclisation product 76 and two-fold 
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deprotection of the ensuing cis-enone gave L-783,277 (5) (40%) without compromising 





























































(e) The Banwell Group Syntheses 
Our syntheses of RALs 5 and 72 were completed just prior to the report5 of the isolation 
and structural characterisation of cochliomycins A-C (7-9, respectively). Given this, the 
presence of the (unusual) acetonide residues within congeners A and B and the novel 
biological properties they display we were attracted to developing syntheses of them. 
Our route19 to the first two of these (viz. the acetonide-containing ones) exploited a late-
stage and highly stereoselective Nozaki−Hiyama−Kishi (NHK)20 reaction to effect the 
necessary macrocyclisation process, a relatively unusual one in terms of its application 
in the synthesis of RALs. 
	 35	
The pivotal elements of the synthetic sequence used are shown in Scheme 7 and 
involved an OCM of the readily available olefin 67 with the D-2-deoxyribose-derived 
and previously reported chiron 77 to give compound 78 (86%). The b-substituted 
styrene 78 was then reacted with the readily prepared homoallylic alcohol 79 in the 
presence of base and so affording, after protection of the phenolic OH group, the ester 
80 (80%). Treatment of ester 80 with TBAF resulted in selective cleavage of the TBS-
ether moiety and oxidation of the resulting and rather sensitive 1°-alcohol with the 
Dess-Martin periodinane then gave the corresponding aldehyde. This was immediately 
engaged in an intramolecular NHK reaction to afford, with high levels of 
diastereocontrol, the SEM ether of cochliomycin B (8) (77%). When this ether was 
treated with TBAF in refluxing THF then cochliomycin B (8) itself was obtained in 
73% yield. In contrast, on treating the SEM ether with HCl in methanol at 22 °C for 1 h 
then congener A (7) (91%) was obtained while extended exposure of the same substrate 
to the same conditions resulted in acetonide group cleavage and formation of the 




































































Scheme 7: The Banwell Group Syntheses of Cochliomycins A and B 
	 36	
 
The end game associated with our approach21 to cochliomycin C (9) was rather different 
and resulted in the identification of a new means for forming the macrolide ring of 
RALs. The reaction sequence started (Scheme 8) with an OCM reaction between the 
readily available alkenes 81 and 82 (the former compound being obtained from L-
tartaric acid) and conventional hydrogenation of the product olefin 83 (88%) to give 
alkane 84 (98%). The anion derived from the last compound was reacted with arene 30 
and thus affording ester 85 (91%), the phenolic group of which was protected as the 
corresponding SEM-ether 86 (94%). A Stille cross-coupling reaction between aryl 
triflate 86 and the alkenylstannane 87 then gave the cinnamyl alcohol 88 (76%) that was 
converted, over three standard steps, into the rather unstable aldehyde 89 (66%). Given 
our previous positive experiences with the NHK reaction we sought to apply this in the 
macrocyclisation of compound 89. However, on exposing this to a mixture of chromous 
chloride and nickel(II) chloride in DMF only the vinylated 12-membered lactone 90 
was obtained (as a single diastereoisomer in 33% yield). In stark contrast, when the 
same substrate was treated with indium in a mixture of water and dichloromethane then 
a Loh-type a-allylation reaction took place and so affording, in a highly 








































































































Scheme 8: The Banwell Group Synthesis of Cochliomycin C 
 
Removal of the acetonide and SEM protecting groups associated with this last 
compound using aqueous acid then gave paecilomycin F (13) that was chlorinated with 
sulfuryl chloride and so affording cochliomycin C (9) in 82% yield. 
 
During the course of our work detailed above Cutler and colleagues reported22 the 
isolation of three new RALs from a fungus Neocosmospora sp. (UM-031509). They 
were named neocosmosins A-C and structures 92-94 (Figure 5) respectively, assigned 
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to them. These RALs were found to co-occur with three previously reported ones, 
namely radiciol (1), monocillin II (95) and monocillin IV (96). Unlike any of the RALs 
we had previously targeted for synthesis, all of the Neocosmospora-derived compounds 
embody a C10-keto residue and three of them (1, 94 and 95) show good binding affinity 
for the human opioid receptors. Accordingly, we sought to develop a synthesis of the 



















































Figure 5: The Structures 92-94 Assigned to Neocosmosins A-C (respectively) and the 
Co-occurring RALs Radiciol (1), Monocillin II (95) and Monocillin IV (96). 
 
Our synthesis of RAL 9223 is shown in Scheme 9 and began with the OCM of styrene 
67 and the unsaturated acetal 97. The product E-alkene 98 (72%) was treated with 
dimethyl dioxirane and the resulting epoxide 99 (quant.) engaged in a Meinwald-type 
rearrangement on exposure to Pd(OAc)2 and n-Bu3P and thus affording ketone 100 
(88%) embodying the pivotal C10 carbonyl unit (RAL numbering) associated with the 
target 92. Acid-catalysed hydrolysis of the acetal moiety within compound 100 afforded 
the corresponding keto-aldehyde 101 (89%) that could be selectively methylenated 
















































































Scheme 9: The Banwell Group Synthesis of RAL 94 
 
Compound 102 was particularly prone to cyclisation on treatment with either acid or 
base. So, for example, when it was heated with p-TsOH in toluene in the presence of 
ethylene glycol (in an effort to prepare the corresponding ketal) then the unsaturated 
lactone 103 (82%) was formed but this could be cleaved with potassium hydroxide in 
aqueous THF and thus gave, after careful acidic work up, keto-acid 104 (96%). 
Compound 104 then served as the nucleophile in a Mitsunobu reaction with the 
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homochiral 2°-alcohol 26 and thus affording the ester 105 (78%) that was itself engaged 
in a RCM reaction using Grubb’s second generation catalyst and so producing the target 
RAL 92 (83%). All of the NMR, IR and MS spectral data acquired on this product 
matched those reported for neocosmosin A. However, while the specific rotation of 
compound 92 was of a similar magnitude to that reported for the natural product it was 
of the opposite sign. As such we concluded that the absolute configuration of 
neocosmosin A had been incorrectly assigned and is, in fact, represented by structure 
ent-92. 
 
The synthesis of compound ent-92 (Scheme 10) involved a trivial adaptation of the 




























Scheme 10: The Banwell Group Synthesis of the True Structure of  
Neocosmosin A (ent-92). 
 
Thus, Mitsunobu coupling of keto-acid 104 with the homochiral 2°-alcohol ent-26 gave 
ester ent-105 (92%) and this underwent an RCM reaction to give neocosmosin A (ent-
92) (67%), the structure of which was confirmed by single-crystal X-ray analysis. 
 
During the course of these studies Das and co-workers reported24 a distinctly different 







New RALs, including ones isolated from marine sources, that display intriguing 
biological properties continue to be reported.25 Studies on the synthesis of such 
compounds have resulted, over the decades, in the identification of a raft of new 
methods for their construction and these have now provided chemists with the capacity 
to prepare new RALs in a predictable manner. As such, completions of total syntheses 
of RALs no longer elicit the excitement they once did.26 Indeed, now synthetic studies 
usually just provide the means by which the assigned structures can be checked and 
additional material can be produced for the purposes of biological profiling/evaluation. 
Of course, the production of analogues is another important activity in this area, perhaps 
the most promising aspect of which would be the production of potentially more 
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ABSTRACT: A total synthesis of the structure, 1, assigned to the
recently reported resorcylic acid lactone (RAL) neocosmosin A
has been established. Olefin-cross metathesis, ring-closing meta-
thesis, palladium-catalyzed Meinwald rearrangement, and Mitsu-
nobu esterification reactions were used as key steps. A late-stage
and simple modification to the reaction sequence also provided
compound ent-1 that, in fact, represents the true structure of the
natural product.
The polyketide-derived resorcylic acid lactones (RALs)have been isolated from a wide range of organisms and are
produced in vivo from malonate and acetate units.1 A significant
number of the members of this large class of natural product
display a fascinating array of biological properties, including
antifungal, antimalarial, mycotoxic, antibacterial, and/or anti-
cancer activities. Indeed, some of them have inspired the
development of analogues that now seem poised to enter the
clinic for, inter alia, the treatment of melanoma and small-cell
lung cancers.1 This situation, coupled with their fascinating
molecular architectures, has prompted extensive studies
directed toward the total synthesis of RALs, and an impressive
array of methods for achieving such ends have emerged.1
In early 2013, Cutler and co-workers reported2 the isolation
of three known and three new RALs from a fungus,
Neocosmospora sp. (UM-0351509), found in the Southern
U.S. The new compounds were named neocosmosins A−C and
assigned structures 1−3,2b respectively (Chart 1). Certain of
these compounds displayed good in vitro binding affinity for
human opioid and cannabinoid receptors, thus suggesting, for
the first time, that some RALs may be useful for modulating
pain. Prompted by such observations, the new structures of the
neocosmosins, and our previous work3 on the assembly of
RALs, we commenced synthetic studies in the area. Our initial
focus was the preparation of the structure, 1, assigned to
neocosmosin A. Herein, we detail total syntheses of compound
1 and its enantiomer (ent-1), thereby establishing, in fact, that it
is the latter structure that corresponds to the natural product
neocosmosin A. During the course of the studies detailed here,
Das and co-workers reported4 a distinct synthesis of compound
ent-1.
The proven effectiveness of ring-closing metatheses (RCMs)
as a means for assembling the 14-membered macrolide of the
RALs3b,5 prompted us to pursue this approach to targets 1 and
ent-1. We also sought to use some of the same building blocks
as employed in our earlier studies.3 A further consideration was
the desire to delay as long as possible the establishment of the
single stereogenic center (C2) associated with the target
compounds in order that the syntheses (of the two
enantiomers) would only diverge at a very late stage.
The opening phase of the syntheses are shown in Scheme 1
and involved an olefin-cross metathesis (OCM) of the
previously reported and readily accessible resorcylic acid
derivative 43c with the known6 unsaturated acetal 5 that is
readily generated from cyclohexene, as detailed in the
Experimental Section. The almost exclusively E-configured
alkene 6 (72%) formed by such means was treated with freshly
prepared dimethyldioxirane7 to give epoxide 7 (quant.) that,
upon exposure to Pd(OAc)2 and n-Bu3P, engaged in a
Meinwald-type rearrangement reaction8 to give ketone 8
(88%). Hydrolysis of the acetal residue within the last
compound was achieved by treating its THF/water solution
Received: March 16, 2015
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with pyridium p-toluenesulfonate (PPTS) at 50 °C for 16 h.
The resulting keto-aldehyde 9 (89%) could be selectively
methylenated using 1.2 mol equivalents of the Wittig reagent
and so affording the terminal olefin 10 in 74% yield.
On the basis of our earlier work,3c we anticipated (Scheme 2)
that reaction of compound 10 with the R-configured and
commercially available unsaturated alcohol 11 in the presence
sodium hydride would deliver diene 12, the substrate required
for the foreshadowed RCM reaction that should complete the
synthesis of target 1. In the event, however, a facile
lactonization of compound 10 took place instead. Thus,
when a mixture of compounds 10 and 11 was treated with
sodium hydride and subjected to an acidic work up, then a
chromatographically separable mixture of lactone 13 (15%) and
the corresponding hydrolysis product 14 (35%) was obtained.
When compound 10 alone was treated with ethylene glycol and
catalytic quantities of p-toluenesulfonic acid (p-TsOH) in
refluxing toluene, then lactone 13 could be obtained as the
exclusive product of the reaction in 82% yield. Furthermore,
treatment of the latter compound with potassium hydroxide in
THF/water afforded, after an acidic workup, the benzoic acid
14 (96%).
The lack of success forming diene 12 by the pathway detailed
above could be circumvented by subjecting commercially
available (S)-(+)-4-penten-2-ol (ent-11) (Scheme 3) to a
Mitsunobu reaction using acid 14 as nucleophile together
with a combination of di-isopropyl azodicarboxylate (DIAD)
and tri(2-furyl)phosphine [P(fur)3]
9 for activating the alcohol.
By such means, the target diene ester 12 was obtained in 78%
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C2 (RAL numbering) by virtue of the operation of the usual
SN2 pathway in the Mitsunobu reaction.
10 The pivotal RCM
reaction of compound 12 could be effected using the Grubbs’
second generation (Grubbs’ II) catalyst11 in refluxing dichloro-
methane, thereby producing crystalline RAL 1 in 83% yield.
The NMR, IR, and MS spectral data obtained on this material
matched those reported2a for neocosmosin A. However, while
the specific rotation of compound 1 was of a similar magnitude
to that reported for the natural product, it was of the opposite
sign, thus suggesting that the absolute configuration (R)
assigned2b to this RAL is incorrect. Accordingly, the synthesis
of compound ent-1 was pursued.
The synthesis of the macrolide ent-1 was readily achieved by
the pathway shown in Scheme 4. This pathway represents a
minor modification of the one used to prepare enantiomer 1.
Thus, ester ent-12 was obtained in 92% yield by engaging (R)-
(+)-4-penten-2-ol (11) in a Mitsunobu esterification reaction
with benzoic acid 14. The ester was then converted, in 67%
yield, into target ent-1 on exposure to the Grubbs’ II catalyst.
The assigned structure was in full accord with the derived
spectral data, but final confirmation of this (including the
illustrated absolute configuration) followed from a single-crystal
X-ray analysis, the details of which are provided in the
Experimental Section and Supporting Information. As revealed
in Table 1, a comparison of the 13C and 1H NMR spectral data
derived from compound ent-1 with those reported for
neocosmosin A revealed an excellent match. Equally signifi-
cantly, the specific rotation of the synthetically derived material
compared very favorably, in terms of both magnitude and sign,
with that reported for the natural product {[α]D
20 −42 (c 0.6,
CHCl3) for ent-1 vs [α]D
25 −43 (c 0.6, CHCl3) reported
2a for
neocosmosin A}.
The studies detailed above have clearly established that the
true structure of the RAL neocosmosin A is represented by ent-
1 and not 1 as suggested by Cutler et al.2b,12 The synthetic
strategy employed here should be readily adapted to the
synthesis of neocosmosins B and C as well as a number of
related RALs, allowing for detailed studies of the capacity of
such compounds to act at human opioid and cannabinoid
receptors and thereby enhancing the possibility of identifying
new agents for managing pain in mammalian systems.
■ EXPERIMENTAL SECTION
General Protocols. Unless otherwise specified, proton (1H) and
carbon (13C) NMR spectra were recorded at room temperature in
base-filtered CDCl3 on a spectrometer operating at 400 MHz for
proton and 100 MHz for carbon nuclei. The signal due to residual
CHCl3 appearing at δH 7.26 and the central resonance of the CDCl3
“triplet” appearing at δC 77.0 were used to reference
1H and 13C NMR
spectra, respectively. 1H NMR data are recorded as follows: chemical
shift (δ) [multiplicity, coupling constant(s) J (Hz), relative integral],
where multiplicity is defined as s = singlet, d = doublet, t = triplet, q =
quartet, m = multiplet, or combinations of the above. Samples were
analyzed by infrared spectroscopy (νmax) as thin films on KBr plates.
Low-resolution ESI mass spectra were recorded on a single quadrupole
liquid chromatograph−mass spectrometer, whereas high-resolution
measurements were conducted on a time-of-flight instrument. Low-
and high-resolution EI mass spectra were recorded on a magnetic-
sector machine. Melting points were measured on an automated
melting point system and are uncorrected. Analytical thin-layer
chromatography (TLC) was performed on aluminum-backed 0.2
mm thick silica gel 60 F254 plates. Eluted plates were visualized using a
254 nm UV lamp and/or by treatment with a suitable dip followed by
heating. These dips included phosphomolybdic acid/ceric sulfate/
sulfuric acid (conc.)/water (37.5 g:7.5 g:37.5 g:720 mL) or potassium
permanganate/potassium carbonate/5% sodium hydroxide aqueous
solution/water (3 g:20 g:5 mL:300 mL). Flash chromatographic
separations were carried out following protocols defined by Still et al.13
with silica gel 60 (40−63 μm) as the stationary phase and using the
AR- or HPLC-grade solvents indicated. Starting materials and reagents
were generally commercially available and were used as supplied.
Drying agents and other inorganic salts were purchased from
commercial suppliers. Tetrahydrofuran (THF), methanol, and
dichloromethane were dried using a solvent purification system that
is based upon a technology originally described by Grubbs et al.14
Where necessary, reactions were performed under a nitrogen or argon
atmosphere.
Compound 5. Step i. Ozone was passed through a magnetically
stirred solution of cyclohexene (15.35 mL, 150 mmol) in dry
dichloromethane (300 mL) containing dry MeOH (100 mL)
maintained at −78 °C (dry ice/acetone bath). Once the reaction
mixture remained blue, nitrogen was bubbled through it until the color
was discharged, at which point it was treated with p-TsOH·H2O (2.90
g, 15 mmol) and the cooling bath was removed. With continuing
stirring, the reaction mixture was allowed to warm to 20 °C (ca. 2 h)
before it was treated, in portions, with Na2CO3 (3.28 g, 39 mmol) and,
after 0.5 h, with Me2S (24 mL, 330 mmol) that was added dropwise
over 0.5 h. The resulting mixture was stirred at 20 °C for 16 h and
then quenched with H2O (200 mL). The separated aqueous phase was
extracted with diethyl ether (4 × 200 mL), and the combined organic
phases were dried (MgSO4), filtered, and concentrated under reduced
pressure. The light-yellow oil thus obtained was purified by flash
chromatography (silica, 4:1 v/v hexane/ethyl acetate elution), and
after concentration of the appropriate fractions (Rf = 0.3 in 9:1 v/v
hexane/ethyl acetate), 6,6-dimethoxyhexanal6 (22.93 g, 95%) was
obtained as a clear, colorless oil. 1H NMR (400 MHz, CDCl3) δ 9.74
(s, 1H), 4.35−4.32 (complex m, 1H), 3.29 (s, 6H), 2.45−2.40
(complex m, 2H), 1.68−1.57 (complex m, 4H), 1.40−1.33 (complex
m, 2H); 13C NMR (100 MHz, CDCl3) δ 202.5, 104.4, 52.9, 43.9, 32.4,
24.3, 22.0; IR νmax 3424, 2947, 2831, 2721, 1726, 1460, 1388, 1366,
1192, 1128, 1074, 1052, 958 cm−1; MS (ESI, +ve) m/z 199 [(M + K)+,
100%], 183 [(M + Na)+, 71]; HRMS (M + Na)+ calcd for
C8H16NaO3, 183.0997; found, 183.0997.
Step ii. A magnetically stirred suspension of MePPh3Br (61.09 g,
167.60 mmol) in dry THF (200 mL) maintained under nitrogen at 0
°C (ice bath) was treated, dropwise over 0.5 h, with n-BuLi (104.7 mL
of a 1.6 M solution in hexanes, 167.6 mmol). The ensuing orange
suspension was stirred at 0 °C for 0.5 h before a solution of 6,6-
Scheme 4
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dimethoxyhexanal (13.43 g, 83.80 mmol) in dry THF (50 mL) was
added dropwise. The resulting yellow mixture was left to warm to 20
°C over 16 h and was then treated with NH4Cl (200 mL of a saturated
aqueous solution). The separated aqueous phase was extracted with
diethyl ether (2 × 200 mL), and the combined organic phases were
washed with brine (1 × 200 mL) before being dried (MgSO4), filtered,
and then concentrated under reduced pressure. The yellow oil thus
obtained was subjected to flash chromatography (silica, 50:1 v/v
hexane/ethyl acetate elution), and concentration of the relevant
fractions (Rf = 0.5 in 9:1 v/v hexane/ethyl acetate) afforded
compound 56 (7.45 g, 56%) as a clear, colorless oil. 1H NMR (400
MHz, CDCl3) δ 5.79 (m, 1H), 5.00−4.91 (complex m, 2H), 4.35 (t, J
= 5.8 Hz, 1H), 3.30 (s, 6H), 2.04 (m, 2H), 1.59 (m, 2H), 1.43−1.30
(complex m, 4H); 13C NMR (100 MHz, CDCl3) δ 138.9, 114.5, 104.6,
52.7, 33.8, 32.5, 28.9, 24.2; IR νmax 3077, 2978, 2929, 2859, 2830,
1641, 1462, 1416, 1385, 1363, 1191, 1127, 1077, 1054, 910 cm−1; MS
(ESI, +ve) m/z 171 [(M + Na)+, 100%], 159 [(M + H)+, 27]; HRMS
(M + Na)+ calcd for C9H18NaO2, 181.1204; found, 181.1205.
Compound 6. A magnetically stirred and degassed mixture of
compound 43c (1.25 g, 5.14 mmol), compound 5 (1.02 g, 6.43 mmol),
Grubbs’ II catalyst (110 mg, 0.13 mmol), and CuI (30 mg, 0.15 mmol)
in dry Et2O (25 mL) was stirred at reflux under an atmosphere of
argon. Grubbs’ II catalyst (110 mg, 0.13 mmol) and CuI (30 mg, 0.15
mmol) were each added seven times every other day, and olefin 5
(1.02 g, 6.43 mmol) every third day and three times in total. After 14
days, the reaction mixture was concentrated under reduced pressure,
and the residue thus obtained subjected to flash chromatography
(silica, 8:1 v/v hexane/ethyl acetate elution) to afford compound 6
(1.35 g, 72%) as a clear, light-yellow oil. 1H NMR (400 MHz, CDCl3)
δ 7.39 (d, J = 15.7 Hz, 1H), 6.69 (d, J = 2.6 Hz, 1H), 6.27 (d, J = 2.6
Hz, 1H), 6.14 (dt, J = 15.7 and 6.9 Hz, 1H), 4.32 (t, J = 5.7 Hz, 1H),
3.79 (s, 3H), 3.26 (s, 6H), 2.23 (m, 2H), 1.64 (s, 6H), 1.58 (m, 2H),
1.48 (m, 2H), 1.38 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 164.7,
160.2, 158.7, 144.2, 135.0, 128.3, 108.1, 104.9, 104.5, 103.7, 100.1,
55.6, 52.7, 33.0, 32.4, 29.0, 25.6, 24.2; IR νmax 2992, 2942, 2857, 1729,
1605, 1573, 1430, 1389, 1275, 1204, 1161, 1128, 1072, 968, 914, 855
cm−1; MS (ESI, +ve) m/z 387 [(M + Na)+, 100%]; HRMS (M + Na)+
calcd for C20H28NaO6, 387.1784; found, 387.1785.
Efforts to accelerate this sluggish reaction using different solvents
and/or microwave irradiation conditions were all unsuccessful.
Compound 7. A magnetically stirred solution of olefin 6 (428 mg,
1.17 mmol) in acetone (3 mL) maintained at 0 °C (ice-bath) was
treated with dimethyldioxirane7 (26 mL of a 67 mM solution in
acetone, 1.76 mmol). The resulting yellow solution was stirred at 20
°C for 16 h and then concentrated under reduced pressure to afford
compound 7 (445 mg, quant.) as a clear, light-yellow oil. 1H NMR
(400 MHz, CDCl3) δ 6.66 (d, J = 2.6 Hz, 1H), 6.32 (d, J = 2.6 Hz,
1H), 4.40 (d, J = 2.2 Hz, 1H), 4.33 (m, 1H), 3.80 (s, 3H), 3.27 (s,
6H), 2.71 (m, 1H), 1.69 (s, 3H), 1.66 (s, 3H), 1.64−1.49 (complex m,
6H), 1.39 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 165.9, 160.1,
158.5, 145.0, 129.2, 106.0, 105.5, 104.5, 104.3, 100.9, 63.4, 57.1, 55.7,
52.6, 32.4, 32.3, 26.4, 25.5, 24.8, 24.5; IR νmax 2944, 2862, 1726, 1670,
1612, 1582, 1442, 1378, 1283, 1203, 1160, 1131, 1068, 963, 913, 854,
751 cm−1; MS (ESI, +ve) m/z 403 [(M + Na)+, 100%], 381 [(M +
H)+, 4]; HRMS (M + Na)+ calcd for C20H28NaO7, 403.1733; found,
403.1733.
Compound 8. A magnetically stirred solution of compound 7
(1.30 g, 3.41 mmol) and Pd(OAc)2 in degassed t-BuOH (60 mL)
maintained at 20 °C under nitrogen was treated with n-Bu3P (860 μL,
3.41 mmol), and the ensuing orange solution was heated at reflux for
16 h. The cooled reaction mixture was concentrated under reduced
pressure, and the residue was subjected to flash chromatography
(silica, 3:1 v/v hexane/ethyl acetate elution) to afford, after
concentration of the appropriate fractions (Rf = 0.2 in 4:1 v/v
hexane/ethyl acetate), compound 8 (1.15 g, 88%) as a clear, light-
yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.36 (d, J = 2.5 Hz, 1H),
6.34 (d, J = 2.5 Hz, 1H), 4.32 (t, J = 5.7 Hz, 1H), 4.07 (s, 2H), 3.79 (s,
3H), 3.28 (s, 6H), 2.58 (t, J = 7.4 Hz, 2H), 1.67 (s, 6H), 1.64−1.55
(complex m, 4H), 1.34 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
206.9, 164.9, 160.8, 159.0, 140.8, 114.1, 105.4, 104.4, 100.2, 55.6, 52.7,
48.6, 42.7, 32.3, 25.6, 24.2, 23.4 (one signal obscured or overlapping);
IR νmax 2989, 2945, 2831, 1724, 1614, 1581, 1436, 1286, 1205, 1161,
1127, 1067 cm−1; MS (ESI, +ve) m/z 403 [(M + Na)+, 100%]; HRMS
(M + Na)+ calcd for C20H28NaO7, 403.1733; found, 403.1734.
Compound 9. A magnetically stirred solution of compound 8 (55
mg, 0.14 mmol) in THF/water (6 mL of a 2:1 v/v mixture) was
treated with PPTS (18 mg, 0.07 mmol), and the ensuing mixture was
stirred at 60 °C for 16 h. The cooled reaction mixture was
concentrated under reduced pressure, the residue was diluted with
water (50 mL), and the ensuing mixture was extracted with




neocosmosin Aa compound ent-1b neocosmosin Ac compound ent-1d
208.2 208.4 11.98, s, 1H 11.98, s, 1H
170.7 170.8 6.44, d, J = 2.5 Hz, 1H 6.42, d, J = 4.0 Hz, 1H
166.0 166.1 6.24, d, J = 2.5 Hz, 1H 6.21, d, J = 4.0 Hz, 1H
163.9 164.0 5.51, m, 1H 5.50−5.38, complex m, 2H
139.1 139.2 5.46, m, 1H
135.1 135.3 5.35, m, 1H 5.32, m, 1H
124.5 124.6 4.42, d, J = 16.8 Hz, 1H 4.38, d, J = 16.7 Hz, 1H
112.1 112.2 3.82, s, 3H 3.79, s, 3H
105.7 105.8 3.51, d, J = 16.8 Hz, 1H 3.48, d, J = 16.7 Hz, 1H
100.1 100.2 2.63, m, 1H 2.59, m, 1H
72.9 73.0 2.55, m, 1H 2.52, m, 1H
55.4 55.5 2.39, m, 1H 2.36, m, 1H
50.2 50.4 2.27, m, 1H 2.25, m, 1H
40.8 40.9 2.09, m, 2H 2.14−2.00, complex m, 2H
37.7 37.8 1.65, m, 2H 1.69−1.40, complex m, 4H
32.7 32.9 1.63, m, 1H
25.2 25.3 1.42, m, 1H
22.1 22.2 1.40, d, J = 6.5 Hz, 3H 1.37, d, J = 6.5 Hz, 3H
18.9 19.0
aData obtained from ref 2a; recorded in CDCl3 at 150 MHz.
bData recorded in CDCl3 at 100 MHz.
cData obtained from ref 2a; recorded in CDCl3
at 500 MHz. dData recorded in CDCl3 at 400 MHz.
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dichloromethane (3 × 30 mL). The combined organic phases were
washed with brine (1 × 50 mL) before being dried (Na2SO4), filtered,
and then concentrated under reduced pressure. The residue was
purified by flash chromatography (silica, 3:1 v/v hexane/ethyl acetate
elution), and concentration of the relevant fractions (Rf = 0.4 in 1:1 v/
v hexane/ethyl acetate) afforded compound 9 (41 mg, 89%) as a clear,
colorless oil. 1H NMR (400 MHz, CDCl3) δ 9.74 (s, 1H), 6.38 (d, J =
2.2 Hz, 1H), 6.36 (d, J = 2.2 Hz, 1H), 4.07 (s, 2H), 3.81 (s, 3H), 2.63
(m, 2H), 2.44 (m, 2H), 1.69 (s, 6H), 1.65 (m, 4H); 13C NMR (100
MHz, CDCl3) δ 206.5, 202.5, 165.0, 160.8, 159.0, 140.6, 114.2, 105.5,
105.3, 100.3, 55.6, 48.7, 43.7, 42.3, 25.6, 23.0, 21.6; IR νmax 2997, 2944,
2725, 1721, 1614, 1581, 1436, 1286, 1205, 1161, 1067 cm−1; MS (ESI,
+ve) m/z 373 [(M + K)+, 96%], 357 [(M + Na)+, 100], 335 [(M +
H)+, 52]; HRMS (M + Na)+ calcd for C18H22NaO6, 357.1314; found,
357.1306.
Compound 10. A magnetically stirred suspension of MePPh3Br
(950 mg, 2.61 mmol) in dry THF (10 mL) maintained at 0 °C under
nitrogen was treated with t-BuOK (2.5 mL of a 1.0 M solution in
THF, 2.50 mmol), and the ensuing yellow suspension was stirred at 0
°C for 0.5 h and then added to a magnetically stirred solution of
compound 9 (726 mg, 2.17 mmol) in dry THF (15 mL) maintained at
−78 °C under a nitrogen atmosphere. The resulting yellow suspension
was stirred at −78 °C for 0.5 h and then 0 °C for 5 h before being
treated, successively, with NH4Cl (10 mL of a saturated aqueous
solution) and water (20 mL) and then extracted with Et2O (3 × 30
mL). The combined organic phases were dried (MgSO4), filtered, and
then concentrated under reduced pressure, and the residue was
subjected to flash chromatography (silica, 6:1 v/v hexane/ethyl acetate
elution). Concentration of the appropriate fractions (Rf = 0.3 in 4:1 v/
v hexane/ethyl acetate) gave olefin 10 (533 mg, 74%) as a clear,
colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.36 (d, J = 2.5 Hz, 1H),
6.33 (d, J = 2.5 Hz, 1H), 5.76 (m, 1H), 4.99−4.88 (complex m, 2H),
4.07 (s, 2H), 3.78 (s, 3H), 2.57 (t, J = 7.4 Hz, 2H), 2.03 (m, 2H), 1.67
(s, 6H), 1.61 (m, 2H), 1.38 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
207.0, 164.9, 160.8, 159.0, 140.8, 138.6, 114.5, 114.1, 105.4, 100.2,
55.6, 48.6, 42.6, 33.6, 28.4, 25.6, 23.1 (signal due to one carbon
obscured or overlapping); IR νmax 2940, 1724, 1614, 1581, 1436, 1285,
1205, 1160, 1067, 911 cm−1; MS (ESI, +ve) m/z 355 [(M + Na)+,
100%], 333 [(M + H)+, 34]; HRMS (M + Na)+ calcd for
C19H24NaO5, 355.1521; found, 355.1521.
Compound 13. Method A. A magnetically stirred solution of
compounds 10 (164 mg, 0.49 mmol) and 11 (67 mg, 0.74 mmol) in
dry THF (3 mL) maintained at 0 °C under a nitrogen atmosphere was
treated with NaH (43 mg of a 55% dispersion in mineral oil, 0.98
mmol). The ensuing mixture was stirred at 20 °C for 2 h and then
quenched with NH4Cl (5 mL of a saturated aqueous solution), diluted
with water (20 mL), and extracted with dichloromethane (3 × 20 mL).
The combined organic phases were washed with brine (1 × 50 mL)
before being dried (Na2SO4), filtered, and concentrated under reduced
pressure. The residue thus obtained was subjected to flash
chromatography (silica, 10:1 v/v hexane/ethyl acetate elution) to
afford two fractions, A and B.
Concentration of fraction A (Rf = 0.5 in 4:1 v/v hexane/ethyl
acetate) afforded compound 13 (20 mg, 15%) as a clear, colorless oil.
1H NMR (400 MHz, CDCl3) δ 11.10 (s, 1H), 6.44 (d, J = 2.4 Hz,
1H), 6.29 (d, J = 2.4 Hz, 1H), 6.16 (s, 1H), 5.79 (m, 1H), 5.06−4.94
(complex m, 2H), 3.85 (s, 3H), 2.49 (t, J = 7.6 Hz, 2H), 2.09 (m, 2H),
1.70 (m, 2H), 1.46 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 166.9,
166.6, 163.8, 157.9, 139.5, 138.4, 115.0, 104.1, 101.2, 100.3, 100.1,
55.8, 33.5, 33.3, 28.3, 26.4; IR νmax 3081, 2932, 2857, 1683, 1646,
1621, 1572, 1511, 1380, 1237, 1163, 1069, 846 cm−1; MS (ESI, +ve)
m/z 297 [(M + Na)+, 100%], 275 [(M + H)+, 2]; HRMS (M + H)+
calcd for C16H19O4, 275.1283; found, 275.1283.
Concentration of fraction B (Rf = 0.2 in 4:1 v/v hexane/ethyl
acetate) afforded a white, amorphous solid. Crystallization of this
material (hexane/ethyl acetate) then gave compound 14 (50 mg, 35%)
as a white, crystalline solid. mp 94−96 °C. 1H NMR (400 MHz,
CDCl3) δ 11.13 (s, 1H), 6.36 (d, J = 2.4 Hz, 1H), 6.29 (d, J = 2.4 Hz,
1H), 5.80 (m, 1H), 5.03−4.95 (complex m, 2H), 3.82 (s, 3H), 3.16 (d,
J = 16.1 Hz, 1H), 3.00 (d, J = 16.1 Hz, 1H), 2.09 (m, 2H), 1.95 (m,
2H), 1.68−1.44 (complex m, 4H) (signal due to carboxylic acid group
proton not observed); 13C NMR (100 MHz, CDCl3) δ 169.3, 166.3,
164.6, 139.1, 138.5, 115.0, 107.6, 104.6, 101.3, 99.7, 55.7, 40.8, 36.8,
33.6, 28.8, 22.9; IR νmax 3377, 2933, 1645, 1629, 1584, 1505, 1439,
1362, 1307, 1205, 1160, 1064, 912 cm−1; MS (ESI, +ve) m/z 315 [(M
+ Na)+, 100%], 293 [(M + H)+, 15]; HRMS (M + H)+ calcd for
C16H21O5, 293.1389; found, 293.1388.
Method B. A magnetically stirred mixture of compound 10 (54 mg,
0.16 mmol), ethylene glycol (198 mg, 3.2 mmol), and p-TsOH·H2O
(6 mg, 0.03 mmol) in toluene (5 mL) was heated at reflux for 16 h in
an apparatus fitted with a Dean−Stark trap topped by a Liebig
condenser. The cooled reaction mixture was partitioned between
dichloromethane (20 mL) and brine/water (20 mL of a 1:1 v/v
mixture). The separated aqueous phase was extracted with dichloro-
methane (3 × 20 mL), and the combined organic phases were washed
with brine (1 × 50 mL) before being dried (Na2SO4), filtered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to flash chromatography (silica, 8:1 v/v hexane/ethyl acetate
elution) affording, after concentration of the appropriate fractions,
compound 13 (37 mg, 82%) as a clear, colorless oil. This material was
identical, in all respects, with that obtained by Method A.
Compound 14. A magnetically stirred solution of compound 10
(382 mg, 1.15 mmol) in THF/H2O (50 mL of a 1:1 v/v mixture) was
treated with KOH (322 mg, 5.75 mmol), and the ensuing yellow
solution was heated at reflux for 16 h. The cooled reaction mixture was
concentrated under reduced pressure, and the residue was acidified,
using HCl (2 M aqueous solution), to pH 1. The suspension thus
formed was diluted with brine (50 mL) and then extracted with ethyl
acetate (3 × 50 mL). The combined organic phases were dried
(MgSO4), filtered, and concentrated under reduced pressure to give a
light yellow oil. The residue so obtained was subjected to flash
chromatography (silica, 2:1:0.01 v/v/v hexane/ethyl acetate/acetic
acid elution) to afford, after concentration of the relevant fractions (Rf
= 0.2 in 4:1 v/v hexane/ethyl acetate), compound 14 (322 mg, 96%)
as a white, amorphous solid. This material was identical, in all respects,
with that obtained by Method A as detailed immediately above.
Compound 12. A magnetically stirred solution of P(fur)3 (164 mg,
0.70 mmol) in benzene (2 mL) was treated with DIAD (175 μL, 0.88
mmol), the ensuing yellow solution was stirred at 20 °C for 10 min,
and then (S)-(+)-4-penten-2-ol (32 mg, 0.37 mmol) was added
dropwise. The resulting mixture was stirred at 20 °C for 5 min and was
then treated, dropwise, with a solution of acid 14 (103 mg, 0.35
mmol) in benzene (7 mL). The ensuing mixture was stirred at 30 °C
for 16 h and then concentrated under reduced pressure. The light-
yellow oil thus obtained was subjected to flash chromatography (silica,
30:1→ 15:1 v/v hexane/ethyl acetate gradient elution) to afford, after
concentration of the relevant fractions (Rf = 0.6 in 4:1 v/v hexane/
ethyl acetate), compound 12 (98 mg, 78%) as a clear, colorless oil.
[α]D
20 −155 (c 0.6, CHCl3). 1H NMR (400 MHz, CDCl3) δ 11.72 (s,
1H), 6.40 (d, J = 2.3 Hz, 1H), 6.21 (d, J = 2.3 Hz, 1H), 5.75 (m, 2H),
5.25 (m, 1H), 5.14−5.09 (complex m, 2H), 4.99−4.91 (complex m,
2H), 4.00 (d, J = 17.2 Hz, 1H), 3.80 (d, J = 17.2 Hz, 1H), 3.76 (s, 3H),
2.47−2.30 (complex m, 4H), 2.02 (m, 2H), 1.57 (m, 2H), 1.35 (m,
2H), 1.28 (d, J = 6.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 207.4,
170.2, 165.8, 164.0, 139.0, 138.5, 133.4, 118.4, 114.7, 112.8, 105.8,
100.1, 72.2, 55.5, 51.4, 41.7, 40.2, 33.6, 28.5, 23.1, 19.5; IR νmax 3077,
2978, 2935, 2853, 1716, 1646, 1616, 1578, 1430, 1356,1322, 1303,
1257, 1204, 1160, 1047, 914 cm−1; MS (ESI, +ve) m/z 383 [(M +
Na)+, 100%], 361 [(M + H)+, 16]; HRMS (M + H)+ calcd for
C21H29O5, 361.2015; found, 361.2016.
Compound 1. A magnetically stirred solution of diene 12 (98 mg,
0.27 mmol) in dichloromethane (150 mL, dry and degassed with
argon) maintained at 20 °C under an argon atmosphere was treated, in
one portion, with Grubbs’ II catalyst (23 mg, 0.027 mmol). The
resulting brown solution was heated at reflux for 24 h, and then
another portion of the Grubbs’ II catalyst (23 mg, 0.027 mmol) was
added. After another 24 h, the reaction mixture was concentrated
under reduced pressure, and the residue thus obtained subjected to
flash chromatography (silica, 15:1 v/v hexane/ethyl acetate elution).
Concentration of the relevant fractions (Rf = 0.5 in 4:1 v/v hexane/
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ethyl acetate) gave a white solid that upon recrystallization (hexane/
dichloromethane) afforded compound 1 (74 mg, 83%) as white
needles. mp 102−103 °C. [α]D20 +40 (c 0.6, CHCl3). All of the NMR,
IR, and MS spectral data recorded on this compound were essentially
identical to those derived from compound ent-1 (see below).
Compound ent-12. A magnetically stirred solution of P(fur)3
(171 mg, 0.74 mmol) in benzene (3 mL) was treated, dropwise, with
DIAD (182 μL, 0.91 mmol), the resulting yellow solution was stirred
at 20 °C for 10 min, and then (R)-(−)-4-penten-2-ol (33 mg, 0.38
mmol) was added. The ensuing mixture was stirred at 20 °C for 5 min
and then treated, dropwise, with a solution of acid 14 (106 mg, 0.36
mmol) in benzene (7 mL). The mixture thus obtained was stirred at
30 °C for 16 h and then concentrated under reduced pressure. The
resulting light-yellow oil was subjected to flash chromatography (silica,
30:1→ 15:1 v/v hexane/ethyl acetate gradient elution) to afford, after
concentration of the relevant fractions (Rf = 0.6 in 4:1 v/v hexane/
ethyl acetate), diene ent-12 (120 mg, 92%) as a clear, colorless oil.
[α]D
20 +158 (c 0.6, CHCl3). All of the NMR, IR, and MS spectral data
recorded on this compound were identical to those derived from
compound 12 (see above).
Compound ent-1. A magnetically stirred solution of diene ent-12
(34 mg, 0.094 mmol) in dichloromethane (10 mL, dry and degassed
with argon) maintained under argon was treated, in one portion, with
Grubbs’ II catalyst (12 mg, 0.014 mmol). The ensuing brown solution
was heated at reflux for 3 h and then concentrated under reduced
pressure. The brown oil thus obtained was subjected to flash
chromatography (silica, 15:1 v/v hexane/ethyl acetate elution).
Concentration of the relevant fractions (Rf = 0.5 in 4:1 v/v hexane/
ethyl acetate) gave a white solid that upon recrystallization (hexane/
dichloromethane) afforded compound ent-1 (20 mg, 67%) as white
needles. mp 102−103 °C (lit.2a mp 160−161 °C), [α]D20 −42 (c 0.6,
CHCl3) {lit.
2a [α]D
25 −43 (c 0.6, CHCl3)}. 1H NMR (400 MHz,
CDCl3) δ see Table 1;
13C NMR (100 MHz, CDCl3) δ see Table 1; IR
νmax 2975, 2934, 2848, 1709, 1646, 1614, 1577, 1381, 1355, 1305,
1257, 1220, 1203, 1161, 1112, 1042, 961 cm−1; MS (ESI, +ve) m/z
355 [(M + Na)+, 100%], 333 [(M + H)+, 19]; HRMS (M + Na)+
calcd for C19H24NaO5, 355.1521; found, 355.1521.
Crystallographic Studies. Crystallographic Data for Com-
pound ent-1. C19H24O5, M = 332.40, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 5.1830(1), b = 12.7946(2), c =
26.0924(3) Å; V = 1730.30(5) Å3, Dx = 1.276 g cm
−3, 3372 unique
data (2θmax = 144.4°), R = 0.033 [for 3320 reflections with I >
2.0σ(I)]; Rw = 0.087 (all data), S = 1.00.
Structure Determination. Images were measured on a CCD
diffractometer (Cu Kα, mirror monochromator, λ = 1.54184 Å), and
data was extracted using the CrysAlis package.15 Structure solution was
by direct methods (SIR92).16 The structure of compound ent-1 was
refined using the CRYSTALS program package.17 Atomic coordinates,
bond lengths and angles, and displacement parameters for compound
ent-1 have been deposited at the Cambridge Crystallographic Data
Centre (CCDC no. 1053186). These data can be obtained free of
charge via www.ccdc.cam.ac.uk/data_request/cif, by emailing data_
request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallo-




Crystallographic data (CIF); anisotropic displacement ellipsoid
plot derived from the single-crystal analysis of compound ent-1;
1H and 13C NMR spectra data for compounds 1, ent-1, 6−10,
12, ent-12, 13, and 14. This material is available free of charge
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ABSTRACT: The title natural product 1 has been synthesized by treating the 1,2,3,5-tetrasubstituted pyrrole 23 with
oxoperoxymolybdenum(pyridine) (hexamethylphosphoric triamide) (MoOPH). Compound 23 was itself prepared in seven
steps from parent pyrrole using Ullmann−Goldberg and Suzuki−Miyaura cross-coupling, Vilsmeier−Haack formylation,
electrophilic bromination, and Wittig olefination reactions as key steps. Related chemistry has been used to prepare discoipyrrole
B (2).
In 2013 MacMillan and co-workers reported1 the isolation,using a functional signature-based ontology (FUSION) map
approach,1,2 of four new alkaloids from the marine-derived
Bacillus hunanensis strain SNA-048. Using a range of relatively
conventional spectroscopic techniques, they assigned structures
1−4 (Figure 1) to these compounds and named them
discoipyrroles A−D, respectively.1 Each was isolated as the
racemate and the structure of the first (viz. 1) was confirmed by
single-crystal X-ray analysis of the bis-p-bromobenzoate
derivative of the (−)-enantiomer obtained using chiral-phase
HPLC techniques.
Discoipyrroles 1, 2, and 4 are the first examples of natural
products that embody a 3H-benzo[d]pyrrole[1,3]oxazine-3,5-
dione core. All four compounds proved to be particularly strong
inhibitors of the discoidin domain receptor 2 or DDR2-
dependent migration of BR5 fibroblasts.1 They also showed
selective cytotoxicity toward DDR2 mutant lung cancer cell lines
(IC50 120−400 nM). As such, these natural products and their
analogues could provide important new tools for interrogating
the DDR2 signaling pathway, one that has been implicated in
various cancers,3 fibroblast migration and proliferation,4 as well
as obstructive diseases of blood vessels.5
The biogenesis of the racemic discoipyrroles is believed to be
nonenzymic in nature and involves, in the case of compound 1,
for example, oxidative coupling of 2-hydroxy-1-(p-hydroxyphen-
yl)-5-methylhexan-3-one and p-hydroxybenzaldehyde with the
resulting 1,3,4-trione engaging in successive inter- then intra-
molecular condensation reactions with the amine and carboxylic
acid residues, respectively, of anthranilic acid.1 Various feeding
experiments have served to support such proposals, and by
mixing the three reaction partners just mentioned in dimethyl
sulfoxide containing 1% trifluoroacetic acid at 50 °C thenmodest
amounts of discoipyrrole A were obtained as an admixture with a
number of side products.1 A variation on this theme has been
Received: December 27, 2015
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Figure 1. Discoipyrroles A−D.
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employed by May and co-workers in an approach to
discoipyrrole D (4).6
The fascinating origins, structures, and biological activities of
the discoipyrroles together with the potential for “tuned”
analogues to serve as molecular probes of the DDR2-mediated
cellular signaling processes prompted us to investigate means for
establishing completely modular (and rational) syntheses of such
systems. Herein, we report the assembly, via successive cross-
coupling and alkenylation chemistries, of compounds of the
general form 5 (Figure 2) and their successful oxidative
cyclization to generate the corresponding 3H-benzo[d]pyrrole-
[1,3]oxazine-3,5-diones 6 including discoipyrroles A and B (1
and 2, respectively).7
The first approach used in attempts to prepare pyrroles of the
general form 5 is shown in Scheme 1 and started with the 2-fold
electrophilic bromination of readily available 1H-pyrrole-2-
carboxaldehyde (7) using N-bromosuccinimide (NBS) and so
affording the previously reported8 dibromo-derivative 8 in 99%
yield. Suzuki−Miyaura cross coupling of this last compound with
5 molar equiv of commercially available p-methoxyphenylbor-
onic acid (9) provided the previously unreported, diarylated
pyrrole 10 in 75% yield.9
On reaction with isopropylmagnesium bromide in THF
aldehyde 10 afforded the expected but unstable secondary
alcohol that was treated, in situ, with lithium aluminum hydride
(LiAlH4), thereby effecting reductive cleavage of the hydroxy
group to produce the isobutyl-substituted pyrrole 11 in 77% yield
(from 10).10
Unfortunately, all attempts to effect the N-arylation of
compound 11 using various methyl o-halobenzoates under a
range of different conditions, including modern variants of the
Ullmann−Goldberg reaction,11 failed. Such outcomes are
attributed to the sterically congested environment about the
nitrogen of pyrrole 11 resulting from the presence of the flanking
aryl and isobutyl groups at C2 and C5, respectively.
In an effort to address the difficulties described immediately
above, a reordering of the cross-coupling and alkylation
processes was investigated as shown in Scheme 2. Thus, pyrrole
(13) was cross-coupled with methyl o-iodobenzoate (14) using
conditions very similar to those reported by Buchwald11a,b and
thereby affording the anticipated and previously reported
product 1512 (99%). Subjection of the latter compound to a
standard Vilsmeier−Haack formylation reaction using N,N-
dimethylformamide (DMF) and POCl3 afforded aldehyde 16
13
(59%), which could be dibrominated with NBS under the same
conditions as described earlier and so delivering the dihalo-
genated product 17 in 99% yield.
Two-fold Suzuki−Miyaura cross-coupling of this last com-
pound with boronic acid 9 then gave the 1,2,3-triarylated pyrrole-
2-carboxaldehyde 18 (73%) that was itself subjected to a Wittig
olefination reaction using the ylide obtained by treating
isopropyltriphenylphosphonium iodide with potassium tert-
butoxide. The isobutene 19 (78%) so formed was subjected to
hydrogenation at atmospheric pressures using palladium on
carbon as catalyst and the targeted C5-isobuylated and triaryl-
substituted pyrrole 12 thereby obtained in 95% yield.
On the basis that the pyrrole ester 12 might undergo an
oxidative cyclization reaction of the type shown in Figure 2, it was
treated with a freshly prepared solution of dimethyldioxirane
(DMDO) in acetone at −78 °C. A rather complex mixture of
products was formed and, after chromatography, the oxidatively
ring-cleaved product 20was obtained in 50% yield. The structure
of this rather unstable compound was secured by single-crystal X-
ray analysis (details provided in the SI). This conversion is
believed to involve initial epoxidation of the Δ4,5-double bond
within substrate 12 with the resulting oxirane then fragmenting,
via successive C−O and C−N bond cleavages, to give the
observed product.
Various studies have been conducted on the oxidation of the
indole C2−C3 double bond using MoO5-based systems, and the
primary products so-generated have been trapped by a range of
external nucleophiles such as methanol so as to generate, for
example, 2-methoxyindolin-3-ones.14 No analogous studies
appear to have been carried out with pyrroles or with any
systems incorporated internal nucleophiles. Since a carboxylic
acid residue was required as an internal nucleophile in the
present instance, the ester 12 was saponified (Scheme 3) using
potassium hydroxide and, after workup with aqueous HCl, the
corresponding carboxylic acid 21 was obtained in 99% yield.
Gratifyingly, when a solution of compound 21 in dichloro-
methane/methanol was treated, at 20 °C for 16 h, with freshly
Figure 2. Proposed oxidative cyclization of a 1,2,3,5-tetrasubstituted
pyrrole 5 to afford the 3H-benzo[d]pyrrole[1,3]oxazine-3,5-dione
framework 6 of discoipyrroles A, B, and D.
Scheme 1. Attempted Synthesis of the 1,2,3,5-
Tetrasubstituted Pyrrole 12 via N-Arylation of Precursor 11
Organic Letters Letter
DOI: 10.1021/acs.orglett.5b03672




phoric triamide) (MoOPH),15 the desired 3H-benzo[d]pyrrole-
[1,3]oxazine-3,5-dione 22 was obtained in 48% yield after
chromatographic purification. All of the spectroscopic data
acquired on this oxidative cyclization product (see the SI for
details) were in complete accord with the assigned structure.
Most particularly, the 13CNMR spectrum displayed the expected
25 resonances, including ones at δC 194.3 and 168.6 that are
assigned to the ketone and lactone carbonyl carbons,
respectively. Furthermore, the infrared spectrum of compound
22 displayed carbonyl stretching bands at 1740 and 1700 cm−1,
while the electrospray ionization mass spectrum revealed
molecular associated ions at m/z 470 [(M + H)+] and 492
[(M + Na) +].
A second substrate, bis-phenol 23, used to examine the scope
of the oxidative cyclization process was obtained in 90% yield
through the boron tribromide-mediated demethylation of
compound 21. On treatment with MoOPH in dichloromethane,
compound 23 was converted into discoipyrrole (1)1 (56%), the
derived spectral data for which proved an excellent match with
those reported for the natural product (see the SI for the 1H and
13C NMR spectral data sets).
The utility of the modular syntheses of 3H-benzo[d]pyrrole-
[1,3]oxazine-3,5-diones reported here is enhanced by the
observation that regioselective Suzuki−Miyaura arylation
reactions of the dibromopyrrole 17 are possible (Scheme
4).8a,16 Thus, for example, when this compound was cross-
coupled with 1.2 molar equiv of boronic acid 9, the diarylated
pyrrole 24 (not isolated) was obtained and immediately engaged
in a second cross-coupling reaction with phenylboronic acid (25)
to give the triarylated pyrrole 26 in 77% yield.
The acquisition of the differentially triarylated pyrrole 26
allowed for the completion of a total synthesis of discoipyrrole B
(2) using the same protocols as described above for the assembly
of congener A (1). Specifically then, compound 26 was
converted into olefin 27 (70%) using the same ylide as employed
previously and the double bond associated with the latter
hydrogenated under conventional conditions to afford the
isobutyl-substituted pyrrole 28 in 95% yield. Saponification of
the last compound then gave, after acidic workup, benzoic acid
29 (99%), the structure of which was confirmed by single-crystal
X-ray analysis. When treated with boron tribromide, aryl methyl
ether 29 was cleaved to give the phenol 30 (82%) that upon
reaction with MoOPH in dichloromethane afforded lactone 2 in
55% yield. The structure of compound 2 was confirmed by
single-crystal X-ray analysis. Furthermore, the derived NMR and
Scheme 2. Synthesis of the 1,2,3,5-Tetrasubstituted Pyrrole
12 and an Attempt To Effect Its Oxidative Cyclization
Scheme 3. Successful Oxidative Cyclization Reactions
Leading to Discoipyrrole A (1) and Its Bis-O-methyl Ether 22
Organic Letters Letter
DOI: 10.1021/acs.orglett.5b03672
Org. Lett. 2016, 18, 704−707
706
71
IR spectral data were in excellent agreement with those reported1
for discoipyrrole B.
While the scope and limitations of the biomimetic route to the
discoipyrroles developed by MacMillan1 have yet to be
delineated, the distinct mode of assembly of the natural product
framework reported here almost certainly means that the two
pathways are likely to be quite complementary in nature.
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A Total Synthesis of the Marine Alkaloid Discoipyrrole D 
 
Yiwen Zhang and Martin G. Banwell* 
 
Research School of Chemistry, Institute of Advanced Studies 




ABSTRACT: A total synthesis of the diastereoisomeric pair of compounds, 4, assigned 
to the marine alkaloid discoipyrrole D is reported. A series of palladium-catalysed 
cross-coupling and other reactions was employed to assemble the relevant 1,2,3,4-tetra-
substituted pyrrole (16) that was engaged in MoOPH-mediated oxidative cyclization 
then conjugate addition and redox processes to complete the synthesis. This work 



































In 2013 MacMillan and co-workers reported on the isolation (from a marine bacterium) 
and structural elucidation of the alkaloids 1-4 (Figure 1), named discoipyrroles A-D 
respectively.1 The occurrence of these compounds as racemic or (in the case of 
compound 4) diastereoisomeric mixtures suggested that they were produced by non-
enzymatic means and the same group was able to mimic the proposed biogenesis in a 
one-pot total synthesis of compound 1 by “incubating” a DMSO solution of p-
hydroxysattabacin, p-hydroxybenzalehyde and anthranilic acid at 50 °C in the presence 
of 1% trifluoroacetic acid.1,2 The generation of analogues of the discoipyrroles by 
related means could well lead to the identification of compounds that show even more 
potent inhibition of the discoidin domain receptor-2 signalling pathway than the natural 
products themselves. In a similar vein, May and co-workers were able to produce a 
brominated analogue of discoipyrrole A bis-O-methyl ether and elaborate this, through 
Heck-type chemistry followed by, inter alia, an organocatalyzed asymmetric conjugate 













1 (R = OH, discoipyrrole A)

















Seemingly, however, the sensitivity of the 3H-benzo[d]pyrrolo[1,3]oxazine-3,5-dione 
core associated with this last compound to the conditions normally used to cleave aryl 
methyl ethers prevented the completion of a synthesis of the natural product, viz. 
discoipyrrole D.3 
 
In 2016 we reported4 a distinctly different route to compounds 1 and 2 that involved the 
assembly, through Ullmann-Goldberg5 and Suzuki-Miyaura cross-coupling 
chemistries,6 of a tetra-substituted pyrrole that could be engaged in an 
oxoperoxymolybdenum (pyridine) hexamethylphosphoric triamide7 or MoOPH-
mediated oxidative cyclization reaction8 resulting in the assembly of the 3H-
benzo[d]pyrrolo[1,3]oxazine-3,5-dione core of discoipyrroles A and B. We have since 
used this modular approach to the discoipyrroles in the construction of a range of 
analogues.9 As an extension of such work we now report on the amalgamation of this 
chemistry with certain aspects of May’s approach3 to discoipyrrole D in the successful 
synthesis of this natural product that serves to confirm the structure originally assigned 
to it by MacMillan and co-workers.1   
 
RESULTS AND DISCUSSION 
The two major considerations associated with our devising an approach to discoipyrrole 
D were, (i), the nature of the protecting group to be used to mask the phenolic hydroxyl 
groups present in the target and, (ii), the timing of MoOPH-mediated oxidative 
cyclization reaction that establishes the 3H-benzo[d]pyrrolo[1,3]oxazine-3,5-dione core 
associated with compound 4. After some preliminary experimentation we elected to 
employ the MOM group to protect the phenolic hydroxyls and to also delay the key 
oxidative cyclization reaction as long as possible because of the seemingly “fragile” 
nature of the core heterocyclic ring system associated with the discoipyrroles.3  
	 150	
The reaction sequence leading to the tetrasubstituted pyrrole that was to be engaged in 
the pivotal oxidative cyclization reaction is shown in Scheme 1 and started with the 
regioselective Ullmann-Goldberg arylation of the parent heterocycle 5 with methyl 5-
bromo-2-iodobenzoate (6) under conditions reported by Buchwald and co-workers.5 
Product 7 (99%) obtained by this means was subjected to a Vilsmeier-Haack reaction10 
and thus affording the pyrrole-2-carboxaldehyde 8 (83%) that was itself subjected to a 
regiocontrolled di-iodination reaction using molecular iodine in the presence of silver 
trifluoroacetate and thereby producing compound 9 (77%). Two-fold Suzuki-Miyaura 
cross coupling of di-iodide 9 with commercially available p-hydroxyphenylboronic acid 
(10) then gave the tri-arylated pyrrole 11 (84%) that was protected, under conventional 
conditions, as the corresponding bis-MOM ether 12 (99%). Wittig olefination of the 
aldehyde residue associated with the last compound using in situ generated 
isopropylenetriphenylphosphorane.11 By such means the olefin 13 (79%) was obtained. 
This was immediately hydrogenated using dihydrogen in the presence of Adam’s 
catalyst and so affording the isobutylated pyrrole 14 (99%) that was itself engaged in a 
Heck reaction with 3,3-diethoxyprop-1-ene using Pd(OAc)2 as the catalyst source. The 
ester residue associated with product 15 (65%) was saponified using sodium hydroxide 
in methanol and upon acidification of the ensuing mixture with aqueous HCl so as to 
generate the free acid the acetal moiety was also hydrolyzed and thus affording the 
cinnamaldehyde 16 (99%), the substrate required for the pivotal oxidation reaction. All 
the spectral data acquired on this tetrasubstituted pyrrole were in complete accord with 











In keeping with earlier observations,4 when compound 16 was treated with freshly 
prepared MoOPH in methanol at ambient temperatures the anticipated oxidative 
cyclization reaction took place and after chromatographic purification of the major 
reaction product compound 17 was obtained in 50% yield as a yellow oil (Scheme 2). 
No other characterizable materials could be isolated from the reaction mixture. The 13C 
NMR spectrum of compound 17 displayed twenty-nine of the expected thirty 
resonances including three at dC 193.8, 193.2 and 167.4 ppm that are attributed to 
carbonyl carbons associated with the ketone, aldehyde and lactone residues, 

























0 to 20 °C, 1 h
83%



























































22 °C, 48 h
99%











at 1740, 1702 and 1679 cm–1 while molecular associated ions at m/z 606 [(M + Na)+] 
and 584 [(M + H)+] dominate the EI mass spectrum.  
 
Scheme 2: MoOPH-mediated oxidative cyclization of pyrrole 16 leading to the 




The completion of the synthesis of target compound 4 is shown in Scheme 3 and proved 
to be a rather straightforward matter. Thus, following the protocols reported by May 
and co-workers,3 compound 17 was subjected to a reaction with the readily prepared 
and N-Boc-protected indole C3-trifluorborate salt 1812 in the presence of the freshly 
prepared catalyst (R)-3,3’-(C7F7)2-BINOL3 and so affording the rather unstable product 
19 as a 1:1 mixture of diastereoisomers. This outcome clearly indicates that the existing 
stereogenic center within substrate 17 has no impact on the configuration of C1 
established during the conjugate addition reaction. By analogy with the work of May, 
this addition reaction is presumed to have proceeded with a high degree of 
stereochemical control and such that the illustrated S-configuration has been established 
at the new stereogenic center. May’s three-step protocol was then employed to 
manipulate the indole-bearing carbon side-chain of compound 19 so as introduce the 
associated hydroxyl groups. Specifically, then, a D-proline-controlled oxidation 
involving nitrosobenzene13 was used to introduce a 2°-phenyaminoxy moiety in a 
stereocontrolled fashion and this was followed by reduction of the aldehyde moiety 














20 °C, 16 h
50%
	 153	
nitrosobenzene resulted in cleavage of the aminoxy residue and so producing diol 20 
(36%) that was also obtained as a 1:1 mixture of diastereoisomers. Subjection of this 
material to analysis on chiral HPLC column very similar to that used by May and co-
workers and using a range of solvent systems only showed peaks due to two 
diastereoisomers and none attributable to the corresponding enantiomers. In the final 
steps of the reaction sequence, compound 20 was treated with trifluoroacetic acid (to 
cleave to Boc group) and then aqueous HCl (to cleave the MOM ethers) and thereby 
affording compound 4 in 60% yield and as a light-yellow oil. 1H and 13C NMR 
spectroscopic analyses of this material revealed the presence of aliphatic impurities 
although the aromatic regions of each spectrum were very clean. The origins of these 
impurities probably reflect the fragile nature of the 3H-benzo[d]pyrrolo[1,3]oxazine-
3,5-dione core of the compound and its partial degradation under the acidic conditions 
necessarily employed in the final steps of the synthesis. Much cleaner samples of 
compound 4 were obtained after purification under reverse-phase HPLC conditions.  
 
All the spectral data acquired on the HPLC-purified sample of compound 4, which 
indicated that it had been generated as a 1:1 mixture of diastereoisomers, proved a good 
match for those reported by MacMillan and co-workers1 on discoipyrrole D (see SI for 
a tabulated comparison of the 13C NMR spectral data sets). Subjection of this material 
to analysis on chiral HPLC column very similar to that used as described above (and, 
once again, using a range of solvent systems) only showed peaks due to two 










The synthetic material was optically active {[a]D25 = +25 (c 0.2, MeOH)}. However, in 
the absence of any published specific rotation data on the title natural product not much 
more can be said about the absolute configuration of the alkaloid.  
 
CONCLUSION 
The total synthesis of discoipyrrole D reported here serves to confirm the basic 
structure (but not the absolute configuration) assigned to it by MacMillan and co-
workers. This work also highlights the capacity of the protocols reported by May and 
his colleagues and to effect the organocatalyzed asymmetric conjugate addition of 
































































study reveals more about the functionality that can be tolerated during the MoOPH-
mediated formation of the above-mentioned heterocyclic core and the various reaction 
conditions that can be used without adversely effecting this same and often rather 






General Protocols. Unless otherwise specified, proton (1H) and carbon (13C) NMR 
spectra were recorded at 18 °C in base-filtered CDCl3 on a spectrometer operating at 
400 MHz for proton and 100 MHz for carbon nuclei. 1H NMR data are recorded as 
follows: chemical shift (δ) [multiplicity, coupling constant(s) J (Hz), relative integral] 
where multiplicity is defined as s = singlet; d = doublet; t = triplet; q = quartet; m = 
multiplet or combinations of the above. In relevant cases, the signal due to residual 
CHCl3 appearing at dH 7.26 and the central resonance of the CDCl3 “triplet” appearing 
at dC 77.0 were used to reference 1H and 13C NMR spectra, respectively. Samples were 
analyzed by infrared spectroscopy (nmax) as thin films on KBr plates or as neat material 
resting on the sampling port. Low- and high-resolution electron impact (EI) mass 
spectra were recorded on a double-focusing, triple-sector machine. Low- and high-
resolution ESI mass spectra were recorded on a triple-quadrupole mass spectrometer 
operating in either positive or negative ion mode. Melting points are uncorrected. HPLC 
analyses were performed on a HPLC system equipped with a photodiode array detector 
and either a C18 reversed phase (150 mm x 4.6 mm, 3 µM silica gel), Chiralpak IA 
(250 mm ´ 4.6 mm, amylose tris-(3,5-dimethylphenylcarbamate) coated on 5 µM silica 
gel) or Chiralpak IC (250 mm ´ 4.6 mm, cellulose tris (3,5-dichlorophenylcarbamate) 
coated on 5 µM silica gel) column. Analytical thin layer chromatography (TLC) was 
performed on aluminum-backed 0.2 mm thick silica gel 60 F254 plates. Eluted plates 
were visualized using a 254 nm UV lamp and/or by treatment with a suitable dip 
followed by heating. These dips included phosphomolybdic acid/ceric sulfate/sulfuric 
acid (conc.)/water (37.5 g : 7.5 g : 37.5 g : 720 mL), potassium 
permanganate/potassium carbonate/5% sodium hydroxide aqueous solution/water (3 g : 
20 g : 5 mL : 300 mL), and p-anisaldehyde or vanillin/sulfuric acid (conc.)/ethanol (15 
	 157	
g : 2.5 mL : 250 mL). Flash chromatographic separations were carried out following 
protocols defined by Still et al.14 with silica gel 60 (40-63 µm) as the stationary phase 
and using the AR- or HPLC-grade solvents indicated. Starting materials, reagents, 
drying agents, and other inorganic salts were generally commercially available and 
were used as supplied. Tetrahydrofuran (THF), methanol and dichloromethane were 
dried using a solvent purification system that is based upon a technology originally 
described by Grubbs et al.15 Where necessary, reactions were performed under a 
nitrogen atmosphere. 
Specific Chemical Transformations. Methyl 5-Bromo-2-(1H-pyrrol-1-yl)benzoate 
(7). A magnetically stirred and degassed mixture of pyrrole (2) (1.39 g, 20.8 mmol), 
commercially available compound 4 (6.45 g, 18.9 mmol), CuI (359 mg, 1.9 mmol), 
1,10-phenanthroline (680 mg, 3.8 mmol) and Cs2CO3 (9.30 g, 28.4 mmol) in anhydrous 
toluene (40 mL) was heated at 100 °C under a nitrogen atmosphere for 48 h. The cooled 
reaction mixture was then passed through a pad of TLC-grade silica and the filtrate 
concentrated under reduced pressure. The residue so formed was subjected to flash 
chromatography (silica, 30:1 v/v hexane/ethyl acetate elution) to afford, after 
concentration of the appropriate fractions (Rf = 0.5 in 8:1 v/v hexane/ethyl acetate), 
compound 7 (5.21 g, 99%) as a clear, colorless syrup. 1H NMR (400 MHz, CDCl3) d 
7.85 (d, J = 2.4 Hz, 1H), 7.59 (dd, J = 8.5 and 2.4 Hz, 2H), 7.18 (m, 1H), 6.71 (m, 2H), 
6.25 (m, 2H), 3.65 (s, 3H); 13C NMR (100 MHz, CDCl3) d 166.1, 139.4, 135.3, 133.5, 
129.4, 128.3, 122.0, 120.5, 110.2, 52.8; IR nmax 2950, 1729, 1594, 1563, 1498, 1435, 
1400, 1329, 1288, 1267, 1238, 1123, 1094, 1015, 966, 922, 826, 727 cm–1; MS (ESI, 
+ve): m/z 282 and 280 [(M+H)+, both 50%], 250 and 248 (96 and 100); HRMS (ESI, 
+ve): (M+H)+ Calcd for C12H1179BrNO2 279.9973; Found 279.9972. 
Methyl 5-Bromo-2-(2-formyl-1H-pyrrol-1-yl)benzoate (8). Anhydrous DMF/THF 
(90 mL of a 4:5 v/v mixture) maintained with magnetic stirring at 0 °C under a nitrogen 
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atmosphere was treated with POCl3 (5.50 mL, 59.5 mmol) and the resulting orange 
reaction mixture was stirred at 0 °C for 0.75 h before being treated, dropwise, with a 
solution of compound 7 (6.47 g, 23.2 mmol) in anhydrous THF (40 mL). The mixture 
so-formed was warmed to 22 °C then stirred at this temperature for 3 h before being 
quenched with ice (100 g). The ensuing mixture was neutralized using NaHCO3 
(saturated aqueous solution) then extracted with diethyl ether (3 ´ 150 mL). The 
combined organic phases were washed with brine (1 ´ 300 mL) before being dried 
(Na2SO4), filtered and then concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 12:1 v/v hexane/ethyl acetate 
elution) to afford, after concentration of the appropriate fractions (Rf = 0.3 in 4:1 v/v 
hexane/ethyl acetate), compound 8 (5.89 g, 83%) as a clear, colorless syrup. 1H NMR 
(400 MHz, CDCl3) d 9.48 (s, 1H), 8.16 (d, J = 2.4 Hz, 1H), 7.71 (dd, J = 8.3 and 2.4 
Hz, 1H), 7.19 (d, J = 8.3 Hz, 1H), 7.09 (dd, J = 4.0 and 1.7 Hz, 1H), 6.94 (m, 1H), 6.43 
(broadened s, 1H), 3.68 (s, 3H); 13C NMR (100 MHz, CDCl3) d 178.7, 164.1, 138.5, 
135.6, 134.0, 133.2, 131.6, 130.4, 129.9, 123.8, 122.5, 110.9, 52.6; IR nmax 3100, 2843, 
1727, 1646, 1489, 1415, 1361, 1284, 1246, 1088, 1075, 1039, 836, 761, 745 cm–1; MS 
(ESI, +ve): m/z 332 and 330 [(M+Na)+, 95 and 100%], 310 and 308 (both 6); HRMS 
(ESI, +ve): (M+H)+ Calcd for C13H1179BrNO3 307.9922; Found 307.9927. 
Methyl 5-Bromo-2-(5-formyl-2,3-diiodo-1H-pyrrol-1-yl)benzoate (9). A 
magnetically stirred mixture of compound 8 (5.89 g, 19.2 mmol) and CF3COOAg in dry 
THF (80 mL) maintained at 0 °C under a nitrogen atmosphere was treated with 
molecular iodine (9.99 g, 39.3 mmol) and the resulting deep-red reaction mixture was 
warmed to 22 °C over 16 h while being protected from light. After this time the reaction 
mixture was filtered through a pad of TLC-grade silica and the filtrate concentrated 
under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 9:1 v/v hexane/THF elution) to afford, after concentration of 
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the appropriate fractions (Rf = 0.5 in 4:1 v/v hexane/ethyl acetate), compound 9 (8.21 g, 
77%) as an amorphous solid. 1H NMR (400 MHz, CDCl3) d 9.13 (s, 1H), 8.27 (d, J = 
2.3 Hz, 1H), 7.79 (dd, J = 8.4 and 2.3 Hz, 1H), 7.21 (s, 1H), 7.09 (d, J = 8.4 Hz, 1H), 
3.70 (s, 3H); 13C NMR (100 MHz, CDCl3) d 176.5, 163.2, 139.4, 138.5, 136.3, 134.7, 
131.8, 130.0, 129.7, 124.0, 100.2, 78.1, 52.9; IR nmax 3446, 3110, 2950, 1730, 1670, 
1488, 1435, 1380, 1351, 1287, 1254, 1096, 835 cm–1; MS (ESI, +ve) m/z 584 and 582 
[(M+Na)+, 100 and 97%], 562 and 560 [(M+H)+, both 33]; HRMS (ESI, +ve): (M+H)+ 
Calcd for C13H979Br127I2NO3 559.7855; Found 559.7855. 
Methyl 5-Bromo-2-(5-formyl-2,3-bis(4-hydroxyphenyl)-1H-pyrrol-1-yl)benzoate 
(11). A magnetically stirred and degassed mixture of compound 9 (1.62 g, 2.91 mmol), 
commercially available boronic acid 10 (910 mg, 6.40 mmol), Pd(PPh3)2Cl2 (163 mg, 
0.23 mmol) and Na2CO3 (1.23 g, 11.64 mmol) in acetonitrile/water (75 mL of a 3:2 v/v 
mixture) was heated at 60 °C for 48 h while being maintained under a nitrogen 
atmosphere throughout this period. The cooled reaction mixture was passed through a 
pad of TLC-grade silica and the filtrate concentrated under reduced pressure. The 
residue thus obtained was subject to flash chromatography (silica, 2:1 v/v hexane/ethyl 
acetate elution) to afford, after concentration of the appropriate fractions (Rf = 0.3 in 1:1 
v/v hexane/ethyl acetate), compound 11 (1.20 g, 84%) as a pale-yellow foam. 1H NMR 
(400 MHz, CD3OD) d 9.38 (s, 1H), 8.00 (d, J = 2.3 Hz, 1H), 7.69 (dd, J = 8.3 and 2.3 
Hz, 1H), 7.36 (s, 1H), 7.21 (d, J = 8.3 Hz, 1H), 7.07 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 
Hz, 2H), 6.67 (d, J = 8.6 Hz, 2H), 6.61 (d, J = 8.6 Hz, 2H), 3.69 (s, 3H) (signals due to 
protons of phenolic hydroxyl groups not observed); 13C NMR (100 MHz, CD3OD) d 
180.1, 165.6, 159.0, 157.2, 142.0, 138.7, 136.3, 134.3, 133.9, 133.6, 133.3, 132.5, 
130.2, 127.1, 127.0, 124.5, 123.0, 122.3, 116.2, 116.1, 53.0; IR nmax 3315, 2954, 2873, 
1732, 1712, 1636, 1612, 1457, 1434, 1419, 1258, 1230, 1159, 1100, 830, 736 cm–1; MS 
(ESI, +ve) m/z 516 and 514 [(M+Na)+, 93 and 100%], 494 and 492 [(M+H)+, 20 and 
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19]; HRMS (ESI, +ve): (M+Na)+ Calcd for C25H1879BrNO5Na 514.0266; Found 
514.0265. 
Methyl 5-Bromo-2-(5-formyl-2,3-bis(4-(methoxymethoxy)phenyl)-1H-pyrrol-1-
yl)benz- oate (12). A magnetically stirred solution of compound 11 (1.26 g, 2.57 
mmol) and N,N-di-isopropylethylamine (3.32 g, 25.7 mmol) in dry dichloromethane (25 
mL) maintained at 0 °C under a nitrogen atmosphere was treated with freshly prepared 
MOMCl (12 mL of an 2.14 M solution in dry dichloromethane, 25.7 mmol). The 
resulting light-yellow reaction mixture was warmed to 22 °C over 16 h then treated, 
successively, with NH4Cl (50 mL of a saturated aqueous solution) and water (100 mL) 
before being extracted with ethyl acetate (3 ´ 100 mL). The combined organic phases 
were washed with brine (1 ´ 150 mL) then dried (Na2SO4), filtered and concentrated 
under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 4:1 v/v hexane/ethyl acetate elution) and concentration of the 
appropriate fractions (Rf = 0.6 in 1:1 v/v hexane/ethyl acetate) gave compound 12 (1.51 
g, 99%) as a pale-yellow foam. 1H NMR (400 MHz, CDCl3) d 9.47 (s, 1H), 8.04 (d, J = 
2.3 Hz, 1H), 7.56 (dd, J = 8.4 and 2.3 Hz, 1H), 7.24 (s, 1H), 7.13 (d, J = 8.8 Hz, 2H), 
7.07 (d, J = 8.4 Hz, 1H), 6.95-6.89 (complex m, 4H), 6.81 (d, J = 8.8 Hz, 2H), 5.14 (s, 
2H), 5.11 (s, 2H), 3.70 (s, 3H), 3.47 (s, 3H), 3.45 (s, 3H); 13C NMR (100 MHz, CDCl3) 
d 178.5, 164.0, 157.4, 156.0, 139.5, 137.2, 135.3, 133.8, 132.5, 132.2, 132.0, 130.9, 
129.2, 128.2, 125.2, 123.4, 123.0, 122.4, 116.2, 116.0, 94.5, 94.4, 56.3, 56.1, 52.6; IR 
nmax 2953, 2902, 2827, 1732, 1662, 1461, 1286, 1235, 1151, 1077, 994, 836 cm–1; MS 
(ESI, +ve) m/z 604 and 602 [(M+Na)+, 100 and 97%], 582 and 580 [(M+H)+, 33 and 
28]; HRMS (ESI, +ve): (M+Na)+ Calcd for C29H2679BrNO7Na 602.0790; Found 
602.0794. 
Methyl 2-(2,3-bis(4-(Methoxymethoxy)phenyl)-5-(2-methylprop-1-en-1-yl)-1H-
pyrrol-1-yl)-5-bromobenzoate (13). A magnetically stirred suspension of i-PrPPh3I 
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(1.44 g, 3.16 mmol) in dry THF (20 mL) maintained at -78 °C under a nitrogen 
atmosphere was treated with n-BuLi (1.82 mL of a 1.6 M solution in hexane, 2.91 
mmol), and the ensuing red suspension stirred at -78 °C for 0.5 h before being added, 
over 0.17 h, to a magnetically solution of compound 12 (1.41 g, 2.43 mmol) in dry THF 
(40 mL) maintained at -78 °C. The reaction mixture thus formed was transferred to an 
ice-water bath and maintained at ca. 0 °C for 1 h then treated, successively, with NH4Cl 
(10 mL of a saturated aqueous solution) and water (40 mL) before being extracted with 
ethyl acetate (3 ´ 50 mL). The combined organic phases were washed with brine (1 ´ 
100 mL) then dried (Na2SO4), filtered and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 15:1 v/v 
hexane/ethyl acetate elution) to afford, after concentration of the appropriate fractions 
(Rf = 0.6 in 4:1 v/v hexane/ethyl acetate), compound 13 (1.16 g, 79%) as a pale-yellow 
foam. 1H NMR (400 MHz, CDCl3) d 7.93 (d, J = 2.4 Hz, 1H), 7.55 (dd, J = 8.4 and 2.4 
Hz, 1H), 7.17 (d, J = 8.8 Hz, 2H), 7.04 (d, J = 8.4 Hz, 1H), 6.90 (m, 4H), 6.78 (d, J = 
8.8 Hz, 2H), 6.45 (s, 1H), 5.49 (s, 1H), 5.14 (s, 2H), 5.11 (s, 2H), 3.64 (s, 3H), 3.48 (s, 
3H), 3.46 (s, 3H), 1.97 (s, 3H), 1.77 (s, 3H); 13C NMR (100 MHz, CDCl3) d 164.9, 
156.4, 155.3, 137.6, 135.3, 135.0, 133.6, 132.8, 132.3, 132.2(4), 132.2(0), 130.4, 129.5, 
129.1, 126.0, 122.8, 121.4, 116.1, 115.9, 114.5, 109.4, 94.7, 94.6, 56.2, 56.0, 52.6, 27.0, 
20.3; IR nmax 2951, 2900, 1733, 1515, 1486, 1284, 1232, 1151, 1077, 999, 834, 731 cm–
1; MS (ESI, +ve) m/z 630 and 628 [(M+Na)+, 100 and 90%], 608 and 606 [(M+H)+, 38 
and 40]; HRMS (ESI, +ve): (M+H)+ Calcd for C32H3379BrNO6 606.1491; Found 
606.1494. 
Methyl 5-bromo-2-(5-isobutyl-2,3-bis(4-(methoxymethoxy)phenyl)-1H-pyrrol-1-
yl)benz-oate (14). A magnetically stirred mixture of compound 13 (4.72 g, 7.80 mmol) 
in dry THF (100 mL) was treated with PtO2•H2O (573 mg, 2.34 mmol) and the ensuing 
black suspension stirred at 22 °C under a balloon of hydrogen for 48 h then filtered 
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through a pad of TLC-grade silica. The filtrate was concentrated under reduced pressure 
and the residue subjected to flash chromatography (silica, 9:1 v/v hexane/ethyl acetate 
elution) to afford, after concentration of the appropriate fractions (Rf = 0.6 in 4:1 v/v 
hexane/ethyl acetate), compound 14 (4.70 g, 99%) as a pale-yellow foam. 1H NMR 
(400 MHz, CDCl3) d 7.92 (d, J = 2.4 Hz, 1H), 7.60 (dd, J = 8.4 and 2.4 Hz, 1H), 
7.18-7.11 (complex m, 3H), 6.91-6.85 (complex m, 4H), 6.76 (d, J = 8.7 Hz, 2H), 6.24 
(s, 1H), 5.13 (s, 2H), 5.10 (s, 2H), 3.64 (s, 3H), 3.47 (s, 3H), 3.46 (s, 3H), 2.25 (dd, J = 
15.2 and 7.0 Hz, 1H), 2.16 (dd, J = 15.2 and 7.2 Hz, 1H), 1.70 (m, 1H), 0.88 (m, 6H); 
13C NMR (100 MHz, CDCl3) d 164.8, 156.3, 155.1, 138.0, 135.2, 133.9, 133.8, 132.8, 
132.3, 132.2, 130.7, 129.6, 128.9, 126.4, 122.0, 121.6, 116.1, 115.8, 107.8, 94.7, 94.6, 
56.3, 56.1, 52.6, 36.3, 27.8, 22.7(8), 22.7(5); IR nmax 2952, 2899, 1737, 1515, 1486, 
1283, 1233, 1151, 1078, 999, 836 cm–1; MS (ESI, +ve) m/z 610 and 608 [(M+H)+, 100 
and 92%], 632 and 630 [(M+Na)+, 90 and 88]; HRMS (ESI, +ve): (M+H)+ Calcd for 
C32H3579BrNO6 608.1648; Found 608.1647. 
Methyl (E)-5-(3,3-Diethoxyprop-1-en-1-yl)-2-(5-isobutyl-2,3-bis(4-
(methoxymethoxy)-phenyl)-1H-pyrrol-1-yl)benzoate (15). A magnetically stirred 
mixture of compound 14 (647 mg, 1.06 mmol), acrolein diethyl acetal (1.38 g, 10.6 
mmol), tetra-n-butylammonium acetate (640 mg, 2.12 mmol), K2CO3 (220 mg, 1.59 
mmol), KCl (80 mg, 1.06 mmol) and Pd(OAc)2 (120 mg, 0.53 mmol) in anhydrous 
DMF (10 mL) was heated at 100 °C in a sealed tube for 48 h. The cooled reaction 
mixture was filtered through a pad of TLC-grade silica and the filtrate concentrated 
under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 9:1 v/v hexane/ethyl acetate elution) to afford, after 
concentration of the appropriate fractions (Rf = 0.5 in 4:1 v/v hexane/ethyl acetate), 
compound 15 (453 mg, 65%) as a clear, yellow oil. 1H NMR [400 MHz, (CD3)2CO] d 
7.86 (s, 1H), 7.73 (d, J = 8.1 Hz, 1H), 7.37 (d, J = 8.1 Hz, 1H), 7.18 (d, J = 8.6 Hz, 2H), 
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7.00 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 6.80 (m, 3H), 6.36 (dd, J = 16.2 and 
4.9 Hz, 1H), 6.27 (s, 1H), 5.15 (s, 2H), 5.10 (m, 3H), 3.73-3.64 (complex m, 5H), 3.55 
(m, 2H), 3.43 (s, 3H), 3.39 (s, 3H), 2.33 (dd, J = 15.0 and 7.1 Hz, 1H), 2.23 (dd, J = 
15.0 and 7.2 Hz, 1H), 1.70 (m, 1H), 1.20 (m, 6H), 0.89 (m, 6H); 13C NMR [100 MHz, 
(CD3)2CO] d 166.5, 157.4, 156.2, 138.9, 137.4, 134.5, 133.3, 132.8, 132.2, 131.9, 
131.4, 130.7, 129.7, 129.5, 127.7, 122.6, 116.9, 116.5, 108.5, 101.9, 95.4, 95.3, 61.7, 
56.3, 56.1, 52.7, 37.2, 28.6, 23.1, 15.9, 15.8; IR nmax 2853, 2898, 1719, 1515,1302, 
1232, 1198, 1150, 1077, 997, 921, 837, 788 cm–1; MS (ESI, +ve): m/z 680 [(M+Na)+, 
15%], 658 [(M+H)+, 100]; HRMS (ESI, +ve): (M+H)+ Calcd for C39H48NO8 658.3380; 
Found 658.3389. 
 (E)-2-(5-Isobutyl-2,3-bis(4-(methoxymethoxy)phenyl)-1H-pyrrol-1-yl)-5-(3-
oxoprop-1-en-1-yl)benzoic acid (16). A magnetically stirred solution of compound 15 
(453 mg, 0.69 mmol) in THF/water/ethanol (20 mL of a 1:1:2 v/v/v mixture) was 
treated with KOH (386 mg, 6.9 mmol) and the ensuing mixture stirred at 22 °C for 24 h 
then acidified, using HCl (2 M aqueous solution), to pH 2. The mixture thus obtained 
was diluted with brine (50 mL) and then extracted with ethyl acetate (3 ´ 50 mL). The 
combined organic phases were washed with brine (3 ´ 100 mL) before being dried 
(Na2SO4), filtered, and then concentrated under reduced pressure. The residue thus 
obtained was subjected to flash chromatography (silica, 3:1 v/v hexane/acetone elution) 
to afford, after concentration of the appropriate fractions (Rf = 0.6 in 1:1 v/v 
hexane/acetone), compound 16 (353 mg, 90%) as a light-yellow oil. 1H NMR (400 
MHz, CDCl3) d 9.71 (d, J = 7.5 Hz, 1H), 8.06 (d, J = 1.6 Hz, 1H), 7.71 (dd, J = 8.3 and 
2.1 Hz, 1H), 7.45 (d, J = 16.0 Hz, 1H), 7.31 (d, J = 8.2 Hz, 1H), 7.12 (d, J = 8.6 Hz, 
2H), 6.91-6.84 (complex m, 4H), 6.75 (dd, J = 16.0 and 7.6 Hz, 1H), 6.69 (d, J = 8.4 
Hz, 2H), 6.24 (s, 1H), 5.12 (s, 2H), 5.04 (s, 2H), 3.46 (s, 3H), 3.41 (s, 3H), 2.29 (dd, J = 
15.2 and 7.0 Hz, 1H), 2.19 (dd, J = 15.2 and 7.2 Hz, 1H), 1.66 (m, 1H), 0.85 (m, 6H) 
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(signal due to carboxylic acid group proton not observed); 13C NMR (100 MHz, CDCl3) 
d 193.4, 169.1, 156.3, 155.1, 150.1, 141.7, 133.6(3), 133.5(9), 132.5, 131.9, 131.8, 
130.5, 130.2, 129.6, 129.0, 126.3, 122.3, 116.1, 115.9, 108.4, 94.7, 94.6, 56.2, 56.1, 
36.4, 27.9, 22.7(2), 22.6(8); IR nmax 2954, 1680, 1515, 1232, 1198, 1150, 1121, 1078, 
999, 920, 837, 731 cm–1; MS (ESI, +ve) m/z 570 [(M+H)+, 100%]; HRMS (ESI, +ve): 
(M+H)+ Calcd for C34H36NO7 570.2492; Found 570.2496. 
 (E)-3-(3a-Isobutyl-1,2-bis(4-(methoxymethoxy)phenyl)-3,5-dioxo-3,3a-dihydro-
5H-ben-zo[d]pyrrole[2,1-b][1,3]oxazin-7-yl)acrylaldehyde (17). A magnetically 
stirred solution of compound 16 (540 mg, 0.95 mmol) in dry methanol (25 mL) 
maintained under a nitrogen atmosphere at 22 °C was treated with MoOPH (825 mg, 
1.9 mmol). The ensuing yellow-colored reaction mixture was stirred, while being 
protected from light, at 22 °C for 16 h then filtered through a pad of TLC-grade silica. 
The filtrate was concentrated under reduced pressure and the residue thus obtained 
subjected to flash chromatography (silica, 2:1 v/v hexane/ethyl acetate elution) to 
afford, after concentration of the appropriate fractions (Rf = 0.3 in 2:1 v/v hexane/ethyl 
acetate), compound 17 (277 mg, 50%) as a light-yellow oil. 1H NMR (400 MHz, 
CDCl3) d 9.69 (d, J = 7.5 Hz, 1H), 8.24 (d, J = 2.1 Hz, 1H), 7.50 (dd, J = 8.8 and 2.2 
Hz, 1H), 7.40 (d, J = 16.0 Hz, 1H), 7.19-7.06 (complex m, 6H), 6.88 (d, J = 8.8 Hz, 
2H), 6.66 (dd, J = 16.0 and 7.5 Hz, 1H), 6.34 (d, J = 8.6 Hz, 1H), 5.26-5.21 (complex 
m, 2H), 5.14-5.09 (complex m, 2H), 3.53 (s, 3H), 3.44 (s, 3H), 2.35 (dd, J = 14.1 and 
5.7 Hz, 1H), 1.97 (dd, J = 14.1 and 7.0 Hz, 1H), 1.83-1.71 (complex m, 1H), 0.94 (d, J 
= 6.7 Hz, 3H), 0.83 (d, J = 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) d 193.8, 193.2, 
167.4, 161.3, 159.4, 156.5, 149.8, 139.1, 133.4, 131.7, 130.4, 130.2(9), 130.2(7), 129.3, 
122.3, 122.1, 122.0, 118.4, 117.0, 116.4, 116.1, 94.6, 94.4, 91.2, 56.6, 56.2, 42.4, 24.1, 
23.1; IR nmax 2959, 1740, 1702, 1679, 1607, 1498, 1389, 1237, 1152, 1121, 1079, 989 
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cm–1; MS (ESI, +ve) m/z 606 [(M+Na)+, 90%], 584 [(M+H)+, 100]; HRMS (ESI, +ve): 
(M+H)+ Calcd for C34H33NO8Na 606.2104; Found 606.2107. 
Potassium [1-(tert-Butoxycarbonyl)-1H-indol-3-yl]trifluoroborate (18). Following a 
procedure reported by Aggarwal,16 a magnetically stirred mixture of 3-Bpin-N-Boc-
indole17 (9.60 g, 28 mmol) in methanol/THF (90 mL of a 7:2 v/v mixture) was treated, 
dropwise at 0 °C, with a solution of KHF2 (9.93 g, 126 mmol) in water (33 mL) and the 
ensuing white suspension was stirred at 20 °C for 3 h then concentrated under reduced 
pressure. The residue thus obtained was re-dissolved in methanol/water (50 mL of a 1:1 
v/v mixture) and all the volatile materials were again removed under reduced pressure. 
This evaporation-dissolution cycle was repeated a further four times and the white solid 
thereby obtained was treated with acetone (100 mL) and ensuing mixture then filtered 
(through filter paper) and the filtrate so-obtained concentrated under reduced pressure. 
The resulting solid was then dried over P2O5 for 16 h to afford compound 1812 (8.99 g, 
99%) as a colorless solid, m.p. = 168-176 °C. 1H NMR (400 MHz, (CD3)2CO) d 8.03 
(d, J = 8.0 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.33 (s, 1H), 7.11 (t, J = 8.0 Hz, 1H), 7.04 
(t, J = 8.0 Hz, 1H), 1.64 (s, 9H); 13C NMR [100 MHz, (CD3)2CO] d 150.7, 137.0, 136.6, 
127.7, 123.8, 122.9, 121.9, 114.8, 82.5, 28.2 (one signal obscured or overlapping); 11B 
NMR (128 MHz, (CD3)2CO) d 3.48; 19F NMR (376 MHz, (CD3)2CO) d -138.3; IR nmax 
2984, 1724, 1706, 1455, 1370, 1250, 1161, 1127, 1084, 983, 928, 900, 754 cm–1; MS 
(ESI, +ve) m/z 362 [(M+K)+, 100%]; HRMS (ESI, +ve): (M+K)+ Calcd for 
C13H14BF3NO2K 362.0344; Found 362.0340. 
tert-Butyl 3-((1R)-1-(3a-Isobutyl-1,2-bis(4-(methoxymethoxy)phenyl)-3,5-dioxo-
3,3a-dihydro-5H-benzo[d]pyrrolo[2,1-b][1,3]oxazin-7-yl)-3-oxopropyl)-1H-indole-
1-carboxyl -ate (19). A magnetically stirred mixture of compound 17 (41 mg, 0.07 
mmol), (R)-3,3’-(C7F7)2-BINOL (25 mg, 0.035 mmol), compound 18 (68 mg, 0.21 
mmol) and molecular sieves (200 mg of 4 Å powdered material) in dry toluene (3 mL) 
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was heated at 80 °C in a sealed tube for 48 h. The cooled reaction mixture was filtered 
through a pad of TLC-grade silica and the filtrate concentrated under reduced pressure. 
The residue thus obtained was subjected to flash chromatography (silica, 2:1 v/v 
hexane/ethyl acetate elution) to afford, after concentration of the appropriate fractions 
(Rf = 0.2 in 2:1 v/v hexane/ethyl acetate), compound 19 (45 mg, 80%) as a 1:1 mixture 
of diastereoisomers and as a clear, light-yellow oil, [a]D24 = +60 (c 0.3, CHCl3). 1H 
NMR (400 MHz, CDCl3) d 9.81 (s, 1H), 8.19-8.03 (complex m, 2H), 7.49 (s, 1H), 
7.34-6.99 (complex m, 10H), 6.88 (m, 2H), 6.28 (m, 1H), 5.27-5.17 (complex m, 2H), 
5.11 (m, 2H), 4.80 (m, 1H), 3.57-3.49 (complex m, 3H), 3.46 (m, 3H), 3.42-3.07 
(complex m, 2H), 2.32 (m, 1H), 2.00-1.87 (complex m, 1H), 1.77-1.66 (complex m, 
10H), 0.96-0.90 (complex 3H), 0.84-0.77 (complex m, 3H); 13C NMR (100 MHz, 
CDCl3) d 199.9, 199.8, 194.1(0), 194.0(7), 168.5(3), 168.5(1), 161.9, 161.8, 159.1, 
156.2, 149.7, 139.4(2), 139.3(6), 136.2, 136.1, 135.9, 134.7, 134.5, 130.6, 130.3, 130.2, 
130.1, 129.7(1), 129.6(5), 129.2(0), 129.1(5), 124.9, 122.9, 122.8(4), 122.7(8), 
122.6(2), 122.6(0), 122.4, 122.3, 122.2, 122.0, 121.7, 121.6, 119.3(3), 119.2(7), 118.2, 
118.1, 116.8, 116.7, 116.0, 115.6(0), 115.5(7), 115.2(8), 115.2(7), 94.5(4), 94.5(2), 
94.4, 91.3, 91.2, 84.2, 56.5, 56.1, 49.0, 48.9, 42.1, 42.0, 35.9, 35.8, 29.8, 28.3, 24.0, 
23.9, 23.1; MS (ESI, +ve) m/z 801 [(M+H)+, 100%]; HRMS (ESI, +ve): (M+H)+ Calcd 
for C47H49N2O10 801.3387; Found 801.3381. 
tert-Butyl 3-((1R,2S)-2,3-Dihydroxy-1-(3a-isobutyl-1,2-bis(4-
(methoxymethoxy)phenyl)-3,5-dioxo-3,3a-dihydro-5H-benzo[d]pyrrolo[2,1-
b][1,3]oxazin-7-yl)propyl)-1H-indole-1-carboxylate (20). A magnetically stirred 
mixture of compound 19 (67 mg, 0.083 mmol) and nitrosobenzene (8.9 mg, 0.083 
mmol) in acetonitrile (0.5 mL) was cooled to 4 °C then treated with D-proline (2.9 mg, 
0.025 mmol). The ensuing and initially green-colored mixture was stirred at 4 °C for 6 
h during which time the color of the mixture turned to yellow (and thus marking the 
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end-point of the a-aminoxylation reaction) and at which stage it was diluted with 1,2-
dichloroethane (2 mL) and treated with NaBH(OAc)3 (145 mg, 0.66 mmol). The 
resulting yellow suspension was stirred at 22 °C for 16 h then treated, successively, 
with NaHCO3 (2 mL of a saturated aqueous solution) and water (10 mL) before being 
extracted with ethyl acetate (3 ´ 10 mL). The combined organic phases were washed 
with brine (1 x 30 mL) then dried (Na2SO4), filtered and concentrated under reduced 
pressure. The residue thus obtained was dissolved in dry dichloromethane (2 mL) and 
the resulting solution cooled to 4 °C before being treated with nitrosobenzene (17 mg, 
0.16 mmol). The ensuing green-colored was mixture was stirred at 4 °C for 4 h and then 
subjected to flash chromatography (silica, 2:3 v/v hexane/ethyl acetate elution) to 
afford, after concentration of the appropriate fractions (Rf = 0.2 in 1:1 v/v hexane/ethyl 
acetate), compound 20 (24.7 mg, 36%) as a clear, yellow oil and a 1:1 mixture of 
diastereoisomers, [a]D24 = -29 (c 0.2, CHCl3). 1H NMR (600 MHz, CD3OD) d 8.13 (d, 
J = 2.1 Hz, 0.5H), 8.11 (d, J = 2.1 Hz, 0.5H), 8.10 (m, 1H), 7.77 (s, 0.5H), 7.75 (s, 
0.5H), 7.51 (m, 0.5H), 7.49 (m, 0.5H), 7.38 (d, J = 7.9 Hz, 0.5H), 7.35 (d, J = 7.8 Hz, 
0.5H), 7.26 (m, 1H), 7.19-7.12 (complex m, 3H), 7.08 (m, 1H), 7.05-7.01 (complex m, 
3H), 6.86 (d, J = 8.9 Hz, 1H), 6.85 (d, J = 8.9 Hz, 1H), 6.38 (d, J = 8.5 Hz, 0.5H), 6.36 
(d, J = 8.5 Hz, 0.5H), 5.23 (s, 1H), 5.19 (m, 1H), 5.11 (s, 2H), 4.42-4.36 (complex m, 
2H), 3.52-3.45 (complex m, 2H), 3.48 (s, 1.5H), 3.44 (s, 1.5H), 3.40 (s, 3H), 2.22-2.14 
(complex m, 1H), 2.04-1.93 (complex m, 1H), 1.80-1.71 (complex m, 1H), 1.69 (s, 
4.5H), 1.68 (s, 4.5H), 0.93 (d, J = 6.7 Hz, 1.5H), 0.92 (d, J = 6.7 Hz, 1.5H), 0.82 (d, J = 
6.7 Hz, 1.5H), 0.81 (d, J = 6.7 Hz, 1.5H) (signals due to hydroxyl group protons not 
observed); 13C NMR (150 MHz, CD3OD) d 196.3(1), 196.2(9), 172.1(0), 172.0(9), 
163.5, 163.4, 160.7, 160.6, 157.7, 151.1, 139.6(2), 139.5(7), 137.6, 137.5, 137.0, 132.5, 
132.4, 131.6, 131.5, 131.4, 131.2, 125.6, 124.3, 124.1, 123.5(9), 123.5(7), 123.4(2), 
123.3(8), 123.1, 122.9, 122.8, 122.7, 120.4, 120.3, 118.8(2), 118.7(9), 117.7(1), 
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117.6(7), 116.9, 116.2(0), 116.1(8), 116.1(5), 116.1, 95.5(0), 95.4(7), 95.4, 92.7, 92.6, 
85.0, 74.4, 74.2, 65.6, 65.5, 56.5(9), 56.5(6), 56.2, 45.0, 43.0, 42.9, 28.4(3), 28.4(2), 
25.2, 25.1, 24.2(1), 24.1(7), 23.5(1), 23.4(9); IR nmax 3449, 2925, 1735, 1611, 1499, 
1453, 1371, 1240, 1155, 1080, 996 cm–1; MS (ESI, +ve) m/z 841 [(M+Na)+, 100%]; 
HRMS (ESI, +ve): (M+Na)+ Calcd for C47H50N2O11Na 841.3312; Found 841.3312. 
7-((1R,2S)-2,3-Dihydroxy-1-(1H-indol-3-yl)propyl)-1,2-bis(4-hydroxyphenyl)-3a-
isobut-yl-5H-benzo[d]pyrrolo[2,1-b][1,3]oxazine-3,5(3aH)-dione (Discoipyrrole D, 
4). A magnetically stirred solution of compound 20 (24.5 mg, 0.03 mmol) in 
dichloromethane (2 mL) was treated with trifluoroacetic acid (460 µL, 6 mmol) and the 
ensuing brown-colored reaction mixture was stirred at 22 °C for 2 h before being 
treated, successively, with NaHCO3 (1 ´ 2 mL of a saturated aqueous solution) and 
water (1 ´ 10 mL) and then extracted with ethyl acetate (3 ´ 10 mL). The combined 
organic phases were washed with brine (1 ´ 30 mL) then dried (Na2SO4), filtered, and 
concentrated under reduced pressure. The residue thus obtained was dissolved in THF 
(2 mL), the resulting solution treated with HCl (2 mL of a 4.0 M aqueous solution) and 
the mixture thus obtained stirred at 22 °C for 3 h before being diluted with NaHCO3 (2 
mL of a saturated aqueous solution) and water (10 mL) then extracted with ethyl acetate 
(3 ´ 10 mL). The combined organic phases were washed with brine (1 ´ 30 mL) then 
dried (Na2SO4), filtered and concentrated under reduced pressure. The yellow oil thus 
obtained was subjected to flash chromatography (silica, 12:1 v/v ethyl 
acetate/isopropanol elution) and thus affording, after concentration of the appropriate 
fractions (Rf = 0.6), compound 4 (11 mg, 60%) as a clear, light-yellow oil and a 1:1 
mixture of diastereoisomers, [a]D25 = +25 (c 0.2, MeOH). For the purposes of 
spectroscopic analysis, a portion of this material was subjected to further purification by 
reversed phase HPLC using 3:7 v/v acetonitrile/water as the eluting solvent at a flow 
rate of 1 mL/min. 1H NMR (800 MHz, CD3OD) d 8.13 (d, J = 2.1 Hz, 0.5H), 8.10 (d, J 
	 169	
= 2.1 Hz, 0.5H), 7.52 (td, J = 8.8 and 2.1 Hz, 1H), 7.42 (d, J = 8.0 Hz, 0.5H), 7.40 (d, J 
= 8.0 Hz, 0.5H), 7.33 (d, J = 8.1 Hz, 0.5H), 7.32 (d, J = 8.1 Hz, 0.5H), 7.31 (s, 0.5H), 
7.30 (s, 0.5H), 7.07 (m, 1H), 7.05⎯7.02 (complex m, 2H), 6.97⎯6.90 (complex m, 3H), 
6.82 (d, J = 8.9 Hz, 1H), 6.80 (d, J = 8.8 Hz, 1H), 6.62 (dm, J = 8.8 Hz, 1H), 6.61 (dm, 
J = 8.8 Hz, 1H), 6.39 (d, J = 8.5 Hz, 0.5H), 6.38 (d, J = 8.5 Hz, 0.5H), 4.43⎯4.40 
(complex m, 1H), 4.36 (d, J = 8.1 Hz, 0.5H), 4.35 (d, J = 8.1 Hz, 0.5H), 3.56 (m, 1H), 
3.45 (complex m, 1H), 2.15 (m, 1H), 1.99 (m, 0.5 H), 1.95 (m, 0.5 H), 1.73 (m, 1H), 
0.91 (t, J = 6.4 Hz, 3H), 0.80 (d, J = 6.7 Hz, 3H) (signals due to OH and NH group 
protons not observed); 13C NMR (200 MHz, CD3OD) d 196.6, 196.5, 172.4(4), 
172.4(2), 163.8, 161.0(6), 161.0(5), 157.6, 141.8(4), 141.8(1), 137.9(8), 137.9(6), 
137.3, 137.2, 136.5, 132.0, 131.9, 131.6, 131.4, 128.0, 123.3(2), 123.3(1), 122.9(2), 
122.8(7), 122.5(9), 122.5(8), 121.8, 121.0(6), 121.0(5), 119.8(3), 119.8(2), 119.5(4), 
119.5(0), 118.6, 118.5, 116.8(8), 116.8(6), 116.7(4), 116.6(7), 116.1, 116.0, 115.9, 
112.4, 112.3, 92.6(4), 92.6(2), 75.3, 75.1, 66.1, 66.0, 46.1(2), 46.0(9), 42.9(6), 42.9(5), 
25.2, 24.2(2), 24.1(9), 23.4(2), 23.4(0) (seventeen signals obscured or overlapping); IR 
nmax 3364, 2959, 2927, 1720, 1612, 1498, 1387, 1273, 1240, 1172, 1070, 1042 cm–1; 
MS (ESI, +ve) m/z  653 [(M+Na)+, 40%], 631 [(M+H)+, 100]; HRMS (ESI, +ve): 




The Supporting Information is available free of charge on the ACS Publications website 
at DOI: 10.1021/acs.joc.7b01192. Tabular comparison of the 13C NMR data reported 
for discoipyrrole D with those recorded on the synthetically derived compound 4. 1H 
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